um accelmed limited partnership private company information  bloomberg july    pm et company overview of um accelmed limited partnership snapshot people company overview um accelmed limited partnership is based in herzliya israel  hachoshlim stherzliya  israel phone     key executives for um accelmed limited partnership um accelmed limited partnership does not have any key executives recorded similar private companies by industry company name region by medimor ltd middle eastafrica pc ltd middle eastafrica  global digital distribution limited ltd middle eastafrica  international economic consulting ltd middle eastafrica biscoil ltd middle eastafrica recent private companies transactions typedate target mergeracquisition september   endochoice holdings inc request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact um accelmed limited partnership please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close accelmed limited partnership um  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors accelmed limited partnership um check out list of companies and businesses related to accelmed limited partnership um find out accelmed limited partnership um address and contact details view other people related to accelmed limited partnership um  coworkers colleagues companions etc address  hachoshlim st herzelia israel companies related to accelmed limited partnership um cikcompany namepositioncompany addressophthalmic imaging systemsdirector  lathrop way suite  sacramento  accelmed limited partnership um on the web persons related to accelmed limited partnership um  ophthalmic imaging systemsnamepositioncityam accelmed management  ltdherzeliajonathan aderethsacramentojonathan aderethdirector sacramentogil allonsacramentogil allonchief executive officer sacramentonoam allonbusiness development officer sacramentoshenhar arielsacramentomoshe arkinherzeliabarak azmondirector sacramentomichael h benoffdirector sacramentoyigal bermansacramentoyigal bermandirector sacramentojohn hampton browndirector sacrementoclerck marc desacramentomaurincomme ericsacramentouri geigerherzeliauri geigerdirector sacramentoallon gilsacramentowilliam d greerdirector sacramentowilliam d greerdirector sacramentoalon harrisdirector sacramentomenachem m inbarsacramentomenachem m inbardirector sacramentophillips jonathansacramentom arkin  ltdherzeliaeric maurincommesacramentomedivision medical imaging ltd owner yokneammedivision medical imaging ltdceo yokneam elitmedivision medical imaging ltd owner yokneam elitmedivision medical imaging ltdceo haifainbar menachemsacramentoarkin moshesacramentojonathan r phillipsdirector sacramentouri ramdirector sacramentoariel shenharsacramentoariel shenharchief financial officer sacramentomerle symesdirector sacramentomerle symesdirector sacaramentoaccelmed limited partnership umdirector herzeliaaccelmed limited partnership umdirector herzeliageiger urisacramentoram urisacramentogreer williamsacramento um accelmed limited partnership ceo and executives  bloomberg july    pm et company overview of um accelmed limited partnership snapshotpeople  overviewboard memberscommittees key executives for um accelmed limited partnership nameboard relationshipstitleagethere is no key executives data available um accelmed limited partnership board members nameboard relationshipsprimary companyagethere is no board members data available um accelmed limited partnership executive committees committee namechairpersonboard relationshipsmembersthere is no committee data available data is at least as current as the most recent definitive proxy request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup ceo compensation in this industry  industry range industry executive changesthere is no executive change data availablesponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact um accelmed limited partnership please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft ophthalmic imaging systems incfka oisi message board  investorshub support   newswire  home  log in boards stocks commodities forex cryptocurrency the lounge hot breakout boards ihub my stocks activity ticker buzz cloud most read most posted most followed members recent news active boards site stats new boards cannabis stocks tools data tools  charts trader alerts trades portfolio top lists price  news alerts commodities markets in d newswire more tools  newsletters my image gallery advanced search videos all news stock screener news filter live charts live news live desktop forex prices commodities etf center educational channel personal finance qa streamer level  follow feed home  boards  us otc  delisted  ophthalmic imaging systems incfka oisi add price alert      hide sticky   hide intro moderator search this board                 created   pm  followers   board type free  posts today  updating soon httptwittercommrgreenpenny  email mrgreenpennyyahoocom  oisi  ophthalmic imaging systems ophthalmic imaging systems wwwoisicom is the leading provider of ophthalmic digital imaging systems the company designs develops manufactures and markets digital imaging systems image management and integrated emrpractice management solutions for the eye care market with over twenty years in the ophthalmic imaging business the company has consistently introduced new innovative technologies through ois whollyowned subsidiary abraxas medical solutions the company provides electronic medical records and practice management software to ophthalmology as well as obgyn orthopedic and primary care the company markets and supports its products through an extensive network of dealers distributors and direct representatives    share structure as of sept   authorized shares  outstanding shares  float    outstanding shares as of november      major holders breakdown  of shares held by all insider and  owners   of shares held by institutional  mutual fund owners   of float held by institutional  mutual fund owners  number of institutions holding shares    insider holders holdersharesreported um accelmed ltd partnership  june   allon gil  december   shenhar ariel  december   phillips jonathan r  may     institutional holders holdersharesreported perritt capital management inc  september   bard associates inc  september   blair william  company l l c  september     mutual fund holder holdersharesreported perritt emerging opportunities fund  september     investor relations kcsa strategic communications todd fromer  garth russell     contacts gil allon ceo   ariel shenhar cfo ashenharoisicom p  f    ophthalmic imaging systems inc  lathrop way suite i sacramento ca  p  f   financials from q as of september   cash and cash equivalents  total current assets  total assets  total current liabilities  total liabilities  sales three months ended september   net income loss   net increase decrease in cash and equivalents  cash and equivalents beginning of the period  cash and equivalents end of the period      ophthalmic imaging systems receives fda clearance to market revolutionary new portable digital imaging device httpinvestorshubadvfncomboardsreadmsgaspxmessageid   all news httpihadvfncompphppidnewscbsymboloisi   all sec filings httpwwwsecgovcgibinbrowseedgarcompanyophthalmicimagingmatchcikfilenumstatecountrysicownerexcludefindfindcompaniesactiongetcompany   ihub message board httpinvestorshubadvfncomboardsboardaspxboardid   charts by mrgreenpenny httpinvestorshubadvfncomboardsreadmsgaspxmessageid    officers and directors name age since current position  phillips jonathan   independent director greer william   independent director maurincomme eric   independent director inbar menachem   independent director geiger uri   director shenhar ariel   chief financial officer vice president secretary director allon gil   chief executive officer director ram uri   chairman of the board   mr gil allon is chief executive officer director of ophthalmic imaging systems he is board of directors since august  and has served as chief executive officer since january  mr allon has acted in the capacity of chief executive officer since august  mr allon is also a member of the compensation option and nominations committees of board of directors mr allon served as the vice president and ief operating officer of medivision from june  until august  mr allon also served as a member of the board of directors of medivision since medivision’s inception in june  through december  mr allon received his ba and msc in computer science both with distinction from the technion israel institute of technology in haifa israel in may  and december  respectively and his mba with distinction in business management from the university of haifa in september    mr uri ram is chairman of the board of ophthalmic imaging systems since march  he was recommended for the director position by yigal berman a former director of board he was appointed as an independent director and chairman of board in march  mr ram is the chairman of the audit committee and a member of the compensation option and nominations committees of board currently he serves as the sr vice president and chief financial officer of gefen inc and is the ceoowner of juram ltd and irams inc management consulting companies that also invests in new startups since  mr ram has served as the president of delta engineering  equipment ltd a holding company with  million in sales and as the senior vp of intergamma investment ltd intergamma investment ltd is a shareholder of medivision medical imaging ltd parent company mr ram has a master of arts degree from israel national defense college and a bachelor of economics and political sciences from bar ilan university and participated in an emba program at the tel aviv university mr ram is a retired brigadier general of the israeli air force   mr ariel shenhar is chief financial officer vice president secretary director of ophthalmic imaging systems he is directors since august  has served as vice president and chief financial officer since july  and has served as secretary since august  mr shenhar also served as a member of the board of directors of medivision from august  through december  and as its vice president and chief financial officer from january  until may  mr shenhar served as a member of the board of directors of fidelity gold real estate markets ltd an israeli public company engaged in real estate from  to  as an accountant at nissan caspi  co certified public accountants in jerusalem israel in  and at witkowski  co certified public accountants in tel aviv israel from  to  mr shenhar received his ba in economics and accounting in june  and his mba in finance with distinction in june  both from the hebrew university in jerusalem israel and has been a certified public accountant since january     recent developments   ophthalmic imaging systems ois receives fda clearance to market revolutionary new portable digital imaging device monday  oct  ophthalmic imaging systems ois announced that its revolutionary new portable imaging device the ois eyescan has received k market clearance from the us food and drug administration fda    ophthalmic imaging systems ois to launch ois eyescan and other new products at american academy of ophthalmologys thursday  oct   ophthalmic imaging systems ois announced that it will launch two new products and improvements to the ois emr and ois pm solutions at the american academy of ophthalmologys aao th annual meeting being held october     at the moscone convention center in san francisco ca the new products are ois eyescanthe ois eyescan is a revolutionary new portable imaging device that is capable of imaging both the anterior and posterior segment of the eye and ois symphony digital reporter    ophthalmic imaging systems ois announces private equity financing monday  jun  ophthalmic imaging systems ois announced it has signed a purchase agreement with um accelmed accelmed limited partnership for a  million private placement of the companys common stock and warrants to be completed in two installments under the terms of the purchase agreement ois may issue up to an aggregate of  shares of its common stock and warrants to purchase up to an aggregate of  shares of its common stock the company intends to use the net proceeds for working capital and general corporate purposes the first installment of  million was completed on june   in the first installment ois sold  shares of common stock at a purchase price of  per share and issued threeyear warrants to purchase up to  shares of common stock at  per share the second installment of  million consisting of  shares of common stock at a purchase price of  per share and warrants to purchase  shares of common stock at  per share is expected to be completed by april      ophthalmic imaging systems ois announces resignation of mr berman as chairmanform k thursday  mar    ophthalmic imaging systems ois announced in its form k that yigal berman has notified the company of his resignation from the companys board of directors the board as a result of health issues effective immediately as of such date mr berman was the chairman of the board and chairman of its audit compensation option and nominations committees of the board on march   the board has appointed mr ram as its chairman as well as chairman of the audit committee and as a member of the compensation option and nominations committees    ophthalmic imaging systems ois to launch seven new products wednesday  nov  ophthalmic imaging systems ois announced that it will launch seven new software solutions the seven new products to be introduced will include ois emr ois pm symphony webtm symphony draw symphony link perfectview and faf superresolution    post new msg follow board my stocks  hide intro view posters poststream bans  show quote filter disabled postsubject older    httpwwwhotstockedcomarticleophthalmicimagingsystemsotcoisiisc vinc   pm    good progress things are on the right mrg   am    but its usually lonely in undiscovered stocks rooms mrg   pm    how long will it take to get noticed mrg   pm    arkin and geiger founded accelmed during the economic mrg   pm    spine implant co nlt raises m the startups mrg   pm    looking better and better here mrg   pm    nice day here talking to self  mrg   pm    looks like the  is broken lets see mrg   am     is such a psychological barrier mrg   pm    about time thats all i can say mrg   am    good luck brick mrg   pm    im resigning as mod it has nothing to brick   pm    trend should resume next week i think mrg   am    yes still too much pain making an exit mrg   pm    things have been quiet  yawn crowded mind   pm    yes but that is not unusual from what mrg   pm     volume am i reading it right crowded mind   pm    shame really this is a nice company and stock crowded mind   pm    i guess we have some people cutting losses mrg   pm    oisi ophthalmic imaging systems dd brick   am    yep the low s are stacked with bids mrg   pm    need better volume than this i am holding crowded mind   pm    looks like the s are gone we will see mrg   pm    looks like some people who bought too high mrg   am    oisi daily and weekly charts nice up trend mrg   pm    ibox updated with all the dd you need brick   pm    this is a rare stock its a dream mrg   pm    website httpwwwoisicom brick   pm    major holders breakdown brick   pm    top mutual fund holders brick   pm    top institutional holders brick   pm    major direct holders forms    brick   pm    contacts gil allon ceo brick   pm    investor relations oisi brick   pm    about ophthalmic imaging systems  oisi brick   pm    oisi ss as of sept   brick   pm     um accelmed limited partnership  initial statement brick   pm     ram uri statement of changes in beneficial brick   pm    for the three months ended september   brick   pm    this should go green next couple of days jimmy   pm    i got in today lets see where this crowded mind   pm    lol theres a couple of peeps you can brick   pm    i would think we would have a huge brick   pm    i gotta run darn it i bet this mrg   pm    i agree brick this is one that i mrg   pm    im in jasmel   pm    historical prices brick   pm    i believe that we should see a good brick   pm    oisi news brick   pm postsubject older post new msg follow board my stocks  hide intro view posters poststream bans  show quote filter disabled   investorshubcom inc about investor relations about us terms of service privacy policy advertise with us data accreditations disclaimer help faq handbook qa forum contact us tutorials educational educational channel stock market  educational videos investor help forum personal finance qa more corporate solutions ihub on facebook ihub on twitter ihub iphoneipad app ihub android app ihub blackberry app ihub newswire you are guest on web   microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft extension agreement  extension agreement  free search  you are here agreements  extension agreement  extension agreement search documents  browse documents site search agreements  contracts document title entire documentoptional governing lawoptional allalabamaalaskaarizonaarkansascaliforniacoloradoconnecticutdelawareflorida georgiahawaiiidahoillinoisindianaiowakansaskentuckylouisianamainemaryland massachusettsmichiganminnesotamississippimissourimontananebraskanevada new hampshirenew jerseynew mexiconew yorknorth carolinanorth dakotaohiooklahoma oregonpennsylvaniarhode islandsouth carolinasouth dakotatennesseetexasutah vermontvirginiawashingtonwest virginiawisconsinwyoming try our advanced search  clauses search contract clauses  browse contract clause library extension agreement extension agreement you are currently viewing  this extension agreement involves ophthalmic imaging systems inc  solomon strategic holdings inc  tail wind fund ltd  realdealdocs™ contains millions of easily searchable legal documents and clauses from top law firms search for free  click here   title extension agreement governing law new york     date  industry medical equipment and supplies     sector healthcare preview edit  save related documents  of the top  law firms use our products every day exhibit    extension agreement   this extension agreement “ amendment ” is made as of this  rd day of june  by and between ophthalmic imaging systems a california corporation “ company ” and the tail wind fund ltd “ tail wind ” and solomon strategic holdings inc “ solomon ” and together with tail wind the “ holders ” witnesseth  whereas pursuant to that certain securities purchase agreement “ purchase agreement ” dated as of october   by and between the company and the holders on or about such date the company sold and issued to the holders i  convertible notes due april   in the aggregate principal amount of  “ notes ” which notes are convertible into shares of common stock of the company no par value per share “ common stock ” and ii warrants to purchase shares of common stock “ warrants ” capitalized terms used herein but not otherwise defined herein shall have the meanings set forth in the purchase agreement notes or warrants as the case may be whereas pursuant to the notes the company is required to make payment of bimonthly amounts until the notes are repaid in full on the maturity date whereas all bimonthly amounts due prior to the date hereof have been paid in full whereas the holders are willing to extend the payment dates for such bimonthly amounts and the maturity date on the terms and conditions set forth herein now therefore in consideration of the foregoing premises and the mutual covenants set forth in this amendment and for other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged the parties hereto agree as follows         extension  in consideration for the new warrants being issued pursuant to section  below and subject to the terms hereof the holders hereby agree that   a each remaining bimonthly payment date under the notes beginning on june   shall be extended by  months such that the next occurring bimonthly payment date shall be december   and thereafter the bimonthly payment dates shall be the last business day of each other calendar month for example the originally scheduled bimonthly payment date for june   shall be extended until and shall occur on december   the originally scheduled bimonthly payment date for august   shall be extended until and shall occur on february   the originally scheduled bimonthly payment date for october   shall be extended until and shall occur on april   and so forth and     b the maturity date under the notes shall be extended until october        provided however that such extensions shall immediately expire and terminate as if this amendment were never entered into in the event that the company fails to receive at least  at a first closing of the common stock financing transaction as defined below on or prior to july   “ financing condition ” in the event that the financing condition is not timely satisfied then  any and all bimonthly amounts which would have been previously due and payable if not for this amendment shall become immediately due and payable  any and all bimonthly amounts with an applicable bimonthly payment date extended hereunder shall become due and payable on the bimonthly payment date set forth in the notes without consideration of this amendment and  the maturity date shall revert to april   subject to acceleration as set forth in the notes for purposes hereof “ common stock financing transaction ” means the sale and issuance of an aggregate of  shares of common stock by the company to um accelmed limited partnership “ accelmed ” in a capital raising financing to occur in two closings provided that a the direct or indirect effective purchase price per share of common stock shall be equal to  for the  shares of common stock sold in the first closing of the common stock financing transaction and  for the  shares of common stock sold in the deferred closing of the common stock financing transaction b the transaction shall not be a variable rate transaction or mfn transaction or otherwise contain any adjustments to such effective sale price per share or any exercise price under any warrants except for weightedaverage antidilution adjustment of the exercise price under warrants in connection with any equity issuances substantially similar to that set forth in the warrants and c the company may issue to the purchasers thereof in connection with any such financing warrants to purchase a number of shares of common stock equal to up to  of the number of shares of common stock sold to such purchasers in such financing provided that the effective exercise price per share of common stock under such warrants shall be equal to  the company represents and warrants to the holders that i it has entered into an agreement to receive  million in the first closing of the common stock financing transaction and ii the purchaser therein has committed to invest an additional  in the deferred closing of the common stock financing transaction contemplated to occur on or prior to june   provided that such second round common stock financing transaction is subject to certain milestones to be achieved by the company which are set forth in such agreement      new warrants  as consideration for the extensions granted by the holders herein the company shall issue and deliver to the holders year warrants to purchase  shares of common stock in the aggregate at an initial exercise price per share equal to  “ new warrants ” the new warrants shall be in the same form as the warrants except that the initial warrant price shall be  the issuance date shall be the date hereof the expiration date shall be three  years from the date hereof and cashless exercise shall be permitted nine  months following the date hereof if there is not an effective registration statement and current prospectus covering the resale of all the shares of common stock underlying the new warrants by the holders such new warrants shall be duly and validly issued and free and clear of all liens claims and encumbrances and shall be delivered to the holders within five  business days after the date hereof      conditions subsequent  the financing condition and the company’s obligation to timely issue the new warrants shall be conditions subsequent to this amendment and if such conditions are not timely made then this amendment shall be null and void as if this amendment were never entered into provided that if the financing condition is not satisfied the holders shall still keep and retain the new warrants without any affect thereon             rule   the company acknowledges and agrees that for purposes of rule  promulgated under the securities act of  as amended “ securities act ” the holding period for the shares of common stock issuable upon conversion or cashless exercise of or otherwise pursuant to the notes andor warrants shall have commenced on october   the date of original issuance of the not tase site  company exalenz bioscnc  profile hebrew    english          security company popular symbol isin index derivative mutual fund      advanced search   homepage       my tase   market data products trading  clearing listings news  events statistics publications rules  regulations about tase   faq invest on tase ipo on tase tase members tase for beginners   more information for public companies tase indices tase derivatives website navigation   exalenz bioscience ltd market data charts historical prices statistics profile analysis  ratios disclosures wwwexalenzcom    issuer no    corporate no    market cap                        nis thousands       tase supersector    tase sector       tase subsector       indices       hightech       biomed       medical devices       tabiomed index tagrowth ta globalbluetech taallshare additional indices       market cap       indices         nis thousands       tabiomed index tagrowth ta globalbluetech taallshare additional indices    company analysis   contact details    phone     fax     dudysexalenzcom    interested parties    interested parties list of interested parties   namebalance datesymbolbalance capital votingmarket cap nis millions moshe arkinexen migdal insurance and financial holdings ltdexen migdal insurance and financial holdings ltdexen u m accelmed limited partnershipexen migdal insurance and financial holdings ltdexen migdal insurance and financial holdings ltdexen smuel rubinsteinexen smuel rubinstein   dr uri geigerexen refael werner   sharon kochan   avi zigelman   gad keren      open in a separate window     non tradable list of securities   namesymbolisinissued and paidup share capitalcapital listed for tradingmarket cap nis millions capital voting exalenzexenil   il    open in a separate window     non tradable indices   as of  namesymbolisinindexweight weight factor exalenzexenilgeneral shares and convertibles  exalenzexenilshares  exalenzexenilta globalbluetech exalenzexenilyeterrest of shares  convertibles  exalenzexenilyeterrest of shares  exalenzexeniltagrowth exalenzexeniltabiomed exalenzexeniltaallshare  export table data   export table data  excel   csv  tsv    open in a separate window     weight factor is calculated for universe indices only index adjusted data for company securities   as of  namesymbolisinindex adjusted no of shares iansindex adjusted free float classindex adjusted free float ratelast ians updateindex adjusted free float market cap nis millions exalenzexenila  export table data   export table data  excel   csv  tsv    open in a separate window     ians  index adjusted number of shares – listed capital for calculation a securitys weight in the index   for more details press here financial statements – key data nis thousands   march  ifrsmarch  ifrsyearly  ifrsbalance sheet total assets current assets non current assets shareholders equity of which minority interest current liabilities longterm liabilitiesprofit  loss statement revenues gross profit operating income income before tax net income income attributable to shareholders earnings per shareadditional data dividends net cash flow generated by operating activitiesfinancial ratios market to book value priceearning ratioloss equityassets ratio  return on equityloss   export table data   export table data  excel   csv  tsv note the financial statements data have been obtained from aonline and they were compiled and processed by it the data have not been examined or audited by the stock exchange and they are presented as given to the stock exchange by aonline the binding data are those appearing in the financial statements published by the company without derogating from the provisions of the use agreement  the stock exchange is not liable for any fault error mistake or inaccuracy in the data presented financial statements published in foreign currency are translated to nis according to the exchange rate at the date of the financial statements financial ratios market capitalization – as of end of previous trading day net income – attributable to the shareholders trailing twelve months shareholders equity attributable to the shareholders average  months start and end of period financial ratios  capital cube   tase indices market data parameters index universe faq market data stocks etnsconvertibles corporate bonds government bonds derivatives market statistics daily review weekly review monthly indicators annual review more information short sales tase companies links data vendors about tase tase products trading on tase listing clearing houses tase members rules  regulations vacation schedule trading schedulesite map contact usterms of use privacy policy ophthalmic imaging systems announces private equity financing  business wire ophthalmic imaging systems announces private equity financing enters agreement to acquire substantially all of the assets of medivision extends payment date and maturity date for its outstanding convertible notes june    am eastern daylight time sacramento califbusiness wireophthalmic imaging systems “ois” or “the company” otcbboisi a leading digital imaging company today announced it has signed a purchase agreement with um accelmed accelmed limited partnership for a  million private placement of the company’s common stock and warrants to be completed in two installments under the terms of the purchase agreement ois may issue up to an aggregate of  shares of its common stock and warrants to purchase up to an aggregate of  shares of its common stock the company intends to use the net proceeds for working capital and general corporate purposes the first installment of  million was completed on june   in the first installment ois sold  shares of common stock at a purchase price of  per share and issued threeyear warrants to purchase up to  shares of common stock at  per share the second installment of  million consisting of  shares of common stock at a purchase price of  per share and warrants to purchase  shares of common stock at  per share is expected to be completed by april   subject to certain conditions the warrants to be issued in the second installment will expire three years from the date of completion of the first installment in connection with the private placement the board of directors of ois appointed dr uri geiger and moshe mori arkin from accelmed to the board effective june   “the private equity financing announced today will provide ois with additional resources to successfully market and sell the electronic medical records emr and practice management pm solutions ois and its subsidiary abraxas medical solutions introduced over the last eight months it will also allow ois to broaden its marketing activities selling ois symphony image management systems as well as promoting other innovative products in the development pipeline” stated gil allon chief executive officer of ois “i am excited to join the board of directors for ois as i believe in the vision of the company to be the leading provider of cutting edge technologies for the eye care market the company has expanded its own offerings with the launch of emr and pm solutions for ophthalmologists and expanded into new medical fields with a wide range of emr and pm solutions through its subsidiary abraxas medical solutions i have great confidence in the ois management team and i believe that together with accelmeds resources and connections ois has a tremendous future” stated dr geiger accelmeds chairman of the board medivision asset purchase agreement and escrow agreement on june   ois entered into an asset purchase agreement with medivision medical imaging ltd medivision an israeli corporation and the majority shareholder of ois to purchase substantially all of medivision’s assets as payment for such assets ois agreed to assume certain liabilities including among other things a bank loan outstanding in an amount not to exceed  and all intercompany indebtedness owed to ois with a principal amount not to exceed  the closing of the asset purchase is subject to a number of conditions including the approval of the asset purchase by the shareholders of medivision if approved by medivision shareholders and if the other conditions of closing are satisfied the asset purchase is expected to close in september  in terms of the  loan agreement ois assumed on behalf of its agreement with medivision on june   ois entered into a direct letter agreement with united mizrahi bank the new loan accrues interest at libor plus  principal payments will be made in  equal monthly installments beginning january   pursuant to the asset agreement with medivision ois entered into an escrow agreement pursuant to which medivision agreed to deposit in an escrow account  shares of ois common stock it owns on the first installment closing date and subject to the status of certain indebtedness another  shares of ois common stock it owns on the closing date of the asset purchase agreement upon medivision’s failure to meet certain obligations as specified under the asset purchase agreement the shares of ois common stock held in escrow will be distributed to ois or sold and the proceeds thereof distributed to ois extension agreement for existing convertible notes on june   ois entered into an extension agreement with the holders of its  convertible notes due april   of which an aggregate principal amount of  remains outstanding under the terms of the extension agreement the holders agreed to extend the payments by  months such that the next payment will be due december   and extend the maturity date of the notes to october   this press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities mentioned in this release this press release is being issued pursuant to and in accordance with rule c under the securities act of  as amended these securities described in this release have not been registered under the securities act of  as amended or any state securities laws and may not be offered or sold in the united states absent an effective registration statement covering such securities or an applicable exemption from such registration requirements about ophthalmic imaging systems ophthalmic imaging systems wwwoisicom is the leading provider of ophthalmic digital imaging systems the company designs develops manufactures and markets digital imaging systems and informatics solutions for the eye care market with over twenty years in the ophthalmic imaging business the company has consistently introduced new innovative technologies through ois’ whollyowned subsidiary abraxas medical solutions the company provides electronic medical records and practice management software to ophthalmology as well as obgyn orthopedic and primary care the company together with medivision one of ois’ major shareholders comarkets and supports its products through an extensive network of dealers distributors and direct representatives about accelmed accelmed is an investment firm focusing on established late stage medical device companies founded by mori arkin and uri geiger and led by a team of accomplished investment professionals with extensive experience in the medical and life science fields accelmed makes strategic investments in promising highgross companies in israel and the us for more information see wwwaccelmedcoil statements in this press release which are not historical data are forwardlooking statements which involve known and unknown risks uncertainties or other factors not under the companys control which may cause actual results performance or achievements of the company to be materially different from the results performance or other expectations implied by these forwardlooking statements these factors include but are not limited to those detailed in the companys periodic filings with the securities and exchange commission contacts ophthalmic imaging systemsgil allon ceo or ariel shenhar cfo orkcsa worldwideinvestor relationstodd fromer garth russell  contacts ophthalmic imaging systemsgil allon ceo or ariel shenhar cfo orkcsa worldwideinvestor relationstodd fromer garth russell  search advanced news search advanced news search log in sign up extension agreement extension contracts  free legal documents page  of   you are here agreements  extension agreement search documents  browse documents site search agreements  contracts document title entire documentoptional governing lawoptional allalabamaalaskaarizonaarkansascaliforniacoloradoconnecticutdelawareflorida georgiahawaiiidahoillinoisindianaiowakansaskentuckylouisianamainemaryland massachusettsmichiganminnesotamississippimissourimontananebraskanevada new hampshirenew jerseynew mexiconew yorknorth carolinanorth dakotaohiooklahoma oregonpennsylvaniarhode islandsouth carolinasouth dakotatennesseetexasutah vermontvirginiawashingtonwest virginiawisconsinwyoming try our advanced search  clauses search contract clauses  browse contract clause library an extension agreement is a document between parties to extend an existing contract the new document changes the duration of the original contract and can contain addendum to the original contract upon signing as well these documents may contain information about the parties in the existing contract the contracts end date and the extensions end datethe parties may choose to add clauses regarding additional provisions in the document as well an agreement may be added to the existing contract so both parties can compare the differencesthese agreements may be used between a manufacturer and a distributor to extend the date of their original contract if both parties are satisfied with the current arrangement they could alter the date to end at a late time the manufacturer may also want to change the original quota in the contract and could do so with a contract extension agreement extension agreements these extension agreements are actual legal documents drafted by top law firms for their clients use them for competitive intelligence drafting documents or to get information about transactions within a particular industry or sector we have millions of legal documents and clauses that you can search for free  debt extension agreementparties passur aerospace inc  megadata corporation  passur aerospace inc document date  governing lawnew york  mortgage consolidation modification and extension agreement dated august   in the original principal amountparties reading international inc  sutton hill properties llc  valley national bank document date  governing lawnew york  extension agreementparties ensco plc  bank of china new york branch  citibank na  deutsche bank ag  dnb bank  dnb capital llc  hsbc bank usa na  pride international inc document date  governing lawnew york  extension agreementparties lattice inc  cantone asset management llc  lattice incorporated document date   extension agreementparties potash corp of saskatchewan inc  bank of america na canada branch  bank of montreal  bank of nova scotia  bank of tokyomitsubishi ufj ltd  banking product services  banking hsbc bank  canadian imperial bank of commerce  credit agricole corporate and investment bank  goldman sachs lending partners llc  morgan stanley bank na  potash corporation  resources energy group  royal bank of canada  saskatchewan inc  sumitomo mitsui banking corporation  torontodominion bank  ubs ag  us bank national association  wells fargo bank na document date  industry chemical manufacturing sector basic materials governing lawontario  second extension agreementparties acre realty investors inc  aiii investment partners llc  roberts realty investors inc document date  industry real estate operations sector services  extension agreementparties lattice inc  cantone asset management llc  lattice incorporated document date  industry communications equipment sector technology  lockup extension agreementparties agrofresh solutions inc  agrofresh solutions inc  boulevard acquisition corp  boulevard acquisition sponsor llc  continental stock transfer trust company  dow chemical company  rohm and haas company document date  industry misc financial services sector financial governing lawdelaware  option exercise period extension agreementparties sally beauty holdings inc  sally beauty holdings inc document date  industry retail specialty sector services governing lawdelaware  extension agreementparties radio one inc  radio one inc document date  industry broadcasting and cable tv sector services  convertible promissory note extension agreementparties rootb technologies inc  rootb technologies inc  ruskin moscou faltischek pc document date  industry software and programming sector technology governing lawnew york  amendment and extension agreement no parties crowdgather inc  crowdgather inc partyaliasand iconic holdings llc  note and iconic holdings llc document date  industry computer services sector technology  extension agreementparties sharpspring inc  rctw llc  sharpspring inc document date  industry computer services sector technology  second lease modification and extension agreementparties shutterstock inc  empire state building company llc  empire state building parent llc  empire state realty trust inc  esrt empire state building gparent llc  esrt empire state building llc  shutterstock inc document date  industry conglomerates sector conglomerates  comprehensive credit extension contractparties applied optoelectronics inc  applied optoelectronics inc  mega international commercial bank document date   amendment and maturity extension agreementparties anadarko petroleum corp  anadarko petroleum corporation  bank of america na  bank of new york mellon  bank of nova scotia  bank of tokyomitsubishi ufj ltd  citibank na  credit agricole corporat and investment bank  credit suisse ag  deutsche bank ag  dnb capital llc  goldman sachs bank  jpmorgan chase bank na  mizuho bank ltd  morgan stanley bank na  standard bank of south africa limited  standard chartered bank  sumitomo mitsui banking corporation  ubs ag  wells fargo bank national association document date  industry oil and gas operations sector energy governing lawnew york  lease extension agreementparties liberator medical holdings inc  liberator medical supply inc  sunshine holdings inc document date  industry retail drugs sector services  loan extension agreementparties healthwarehousecom inc  bank of kentucky inc  bbt corporation  cheviot savings bank  healthwarehousecom inc  hockscom inc  hwarehcom inc  melrose capital advisors llc document date  industry retail drugs sector services governing lawohio  second amendment and extension agreementparties agl resources inc  agl resources inc  ams corp  bank of america na  bank of nova scotia  bank of tokyomitsubishi ufj ltd  branch banking and trust company  fifth third bank  goldman sachs bank  jpmorgan chase bank na  morgan stanley bank na  northern illinois gas company  northern trust company  pnc bank national association  southern company  suntrust bank  td bank na  us bank national association  wells fargo bank national association document date  industry natural gas utilities sector utilities governing lawnew york  second amendment and extension agreementparties agl resources inc  agl capital corporation  ams corp  bank of america na  bank of nova scotia  bank of tokyomitsubishi ufj ltd  branch banking and trust company  fifth third bank  goldman sachs bank  jpmorgan chase bank na  morgan stanley bank na  northern trust company  pnc bank national association  southern company  suntrust bank  td bank na  us bank national association  wells fargo bank national association document date  industry natural gas utilities sector utilities governing lawnew york  extension agreementparties ncr corp  marcato group  marcato international master fund ltd  ncr corporation document date  industry software and programming sector technology governing lawnew york  extension agreement and amendment no  to credit agreementparties diamond offshore drilling inc  bank of china new york branch  bank of tokyomitsubishi ufj  citibank na  diamond offshore drilling inc  goldman sachs bank  hsbc bank  issuing bank  jpmorgan chase bank na  royal bank of canada  suntrust bank  wells fargo bank national association law firm duane morris document date  industry oil well services and equipment sector energy governing lawnew york  hongli clean energy technologies corp reaches loan extension agreement with bairui trustparties hongli clean energy technologies corp  about hongli clean energy technologies corp  bairui trust co ltd  baofeng xingsheng coal mining co ltd  henan province pingdingshan hongli coal coke co ltd baofeng coking factory baofeng hongchang coal co ltd baofeng hongguang environment protection electricity generating co ltd zhonghong energy investment company henan hongyuan coal seam gas engineering technology co ltd baofeng shuangri coal mining co ltd  pingdingshan hongyuan energy science and technology development co ltd  sinocoking coal and coke chemical industries inc hongli clean energy technologies corp  top favour limited document date  industry coal sector energy  loan extension agreementparties synthesis energy systems inc  shandong weijiao group xuecheng energy co ltd  synthesis energy systems zaozhuang new gas company ltd document date  industry oil and gas operations sector energy  extension agreementparties authentidate holding corp document date  industry software and programming sector technology governing lawnew jersey  modification and extension agreementparties anpath group inc  anpath group inc document date  industry personal and household prods sector consumernoncyclical  employment extension agreementparties pepco holdings inc  exelon corporation  pepco holdings inc document date  industry electric utilities sector utilities governing lawdistrict of columbia  thirteenth extension agreementparties far east energy corp  far east energy bermuda ltd  far east energy corporation  standard chartered bank document date  industry oil and gas operations sector energy  amendment no  to credit agreement and extension agreementparties midcoast energy partners lp  bank of america na  bank of tokyomitsubishi ufj ltd  citibank na  credit suisse ag  deutsche bank ag  enbridge energy marketing llc  enbridge holdings texas systems llc  enbridge marketing us llc  enbridge pipelines louisiana liquids llc  enbridge pipelines oklahoma transmission llc  goldman sachs bank  jpmorgan chase bank na  midcoast energy partners lp  midcoast holdings llc  midcoast olp gp llc  midcoast operating lp  mizuho bank ltd  sumitomo mitsui banking corporation  wells fargo bank na document date  governing lawnew york  extension agreementparties ecosphere technologies inc  brisben water solutions llc  ecosphere mining llc  ecosphere technologies inc  fidelity national environmental solutions llc  green systems inc document date  industry oil well services and equipment sector energy governing lawflorida  extension agreementparties ecosphere technologies inc  ecosphere technologies inc  green systems inc  heller capital partners llc  heller family foundation inc document date  industry oil well services and equipment sector energy governing lawflorida  extension agreementparties uas drone corp  uas drone corp document date   eleventh extension agreementparties far east energy corp  far east energy bermuda ltd  far east energy corporation  standard chartered bank document date  industry oil and gas operations sector energy  third omnibus loan modification and extension agreementparties alexanders inc  alexanders rego shopping center inc  us bank national association  vornado realty trust document date  industry real estate operations sector services governing lawnew york  milestone extension agreement columbia university  corixa  chinook  introgen therapeutics mda   geneparties multivir inc  chinook corporation  columbia university  corixa corporation  genquest inc  introgen therapeutics inc document date   second modification and extension agreementparties stratus properties inc  austin  properties inc  circle c gp llc  circle c land lp  comerica bank  stratus properties operating co lp  strs llc  thompson knight llp law firm thompson knight document date  industry real estate operations sector services governing lawtexas  eighth extension agreementparties far east energy corp  far east energy bermuda ltd  far east energy corporation  standard chartered bank document date  industry oil and gas operations sector energy  commitment increase and extension agreementparties enlink midstream partners lp  amegy bank national association  bank of america na  bank of montreal  bank of tokyomitsubishi ufj ltd  citibank na  comerica bank  compass bank  credit agricole corporate and investment bank  credit suisse ag  crosstex energy lp  deutsche bank ag  enlink midstream gp llc  fifth third bank  goldman sachs bank  huntington national bank  jpmorgan chase bank na  morgan stanley bank na  pnc bank national association  raymond james bank na  regions bank  royal bank of canada  royal bank of scotland plc  scotiabanc inc  sumitomo mitsui banking corporation  suntrust bank  ubs ag  us bank national association  wells fargo bank na law firm bracewell giuliani document date  industry oil well services and equipment sector energy governing lawnew york  second loan amendment and extension agreementparties location based technologies inc  location based technologies inc document date  industry communications equipment sector technology governing lawcalifornia  third loan amendment and extension agreementparties location based technologies inc  location based technologies inc document date  industry communications equipment sector technology governing lawcalifornia  extension agreementparties oakridge global energy solutions inc  expedia holdings limited  oak ridge energy technologies inc document date  industry electronic instr and controls sector technology  extension agreement extension of maturity date pursuant to section  of the credit agreementparties devon energy corpde  bank of america na  bank of montreal  bank of nova scotia  bank of tokyomitsubishi ufj ltd  canadian imperial bank of commerce new york agency  citibank na  credit suisse ag  devon canada corporation  devon energy corporation  devon financing company llc  devon nec corporation  goldman sachs bank  jpmorgan chase bank na  morgan stanley bank na  royal bank of canada  royal bank of scotland plc  ubs ag  us bank national association  wells fargo bank na document date  industry oil and gas operations sector energy governing lawnew york  second extension agreementparties westar energy inc ks  bank of america na the bank of new york mellon union bank na  bank of tokyomitsubishi ufj ltd  citibank na  goldman sachs bank  jpmorgan chase bank na  kansas gas and electric company  umb bank  us bank national association  wells fargo bank national association  westar energy inc law firm davis polk document date  industry electric utilities sector utilities governing lawnew york  third extension agreementparties far east energy corp  far east energy bermuda ltd  far east energy corporation  standard chartered bank law firm baker mckenzie document date  industry oil and gas operations sector energy  loan amendment and extension agreementparties location based technologies inc  florance accountancy corp  location based technologies inc document date  industry communications equipment sector technology governing lawcalifornia  loan amendment and extension agreementparties location based technologies inc  location based technologies inc document date  industry communications equipment sector technology governing lawcalifornia  loan amendment and extension agreementparties location based technologies inc  location based technologies inc document date  industry communications equipment sector technology governing lawcalifornia  loan amendment and extension agreementparties location based technologies inc  location based technologies inc document date  industry communications equipment sector technology governing lawcalifornia  loan amendment and extension agreementparties location based technologies inc  location based technologies inc document date  industry communications equipment sector technology governing lawcalifornia  loan amendment and extension agreementparties location based technologies inc  location based technologies inc document date  industry communications equipment sector technology governing lawcalifornia browse by statego directly to a specific page of results asset purchase agreement among seaspine holdings corporation nlt spine ltd and nlt spine inc august    purchase and sale agreement  free search  you are here agreements  purchase and sale agreement  asset purchase agreement among seaspine holdings corporation nlt spine ltd and nlt spine inc august   search documents  browse documents site search agreements  contracts document title entire documentoptional governing lawoptional allalabamaalaskaarizonaarkansascaliforniacoloradoconnecticutdelawareflorida georgiahawaiiidahoillinoisindianaiowakansaskentuckylouisianamainemaryland massachusettsmichiganminnesotamississippimissourimontananebraskanevada new hampshirenew jerseynew mexiconew yorknorth carolinanorth dakotaohiooklahoma oregonpennsylvaniarhode islandsouth carolinasouth dakotatennesseetexasutah vermontvirginiawashingtonwest virginiawisconsinwyoming try our advanced search  clauses search contract clauses  browse contract clause library asset purchase agreement among seaspine holdings corporation nlt spine ltd and nlt spine inc august   purchase and sale agreement you are currently viewing  this purchase and sale agreement involves seaspine holdings corp  nlt spine ltd  nlt spine inc  seaspine holdings corporation realdealdocs™ contains millions of easily searchable legal documents and clauses from top law firms search for free  click here   title asset purchase agreement among seaspine holdings corporation nlt spine ltd and nlt spine inc august   governing law new york     date  law firm dla piper     preview edit  save related documents  of the top  law firms use our products every day     exhibit a   certain confidential information contained in this document marked by bracketed asterisks  has been omitted and filed separately with the securities and exchange commission pursuant to rule b of the securities exchange act of  as amended         asset purchase agreement among seaspine holdings corporation nlt spine ltd and nlt spine inc august             table of contents   page     article  definitions   definitions   interpretation  article  purchase and sale   purchase and sale   assets not to be transferred   liabilities and obligations   consideration   milestone payments   contingent asset purchase payments   seller acknowledgement setoff rights   transfer taxes   allocation of purchase price   withholding  article  closings   the initial closing   the subsequent closing  article  representations and warranties of seller   organization   authorization   taxes   compliance with laws   governmental permits   title to purchased assets   intellectual property   no accounts receivable no inventory books of account   contracts   no litigation   environmental matters      i           table of contents continued page      no finder   no customers   seller financial statements   no changes   insurance   fda and regulatory matters   products product liability     no royalties or similar payments to third parties   investment representations   representations by nonus persons   solvency   full disclosure  article  representations and warranties of buyer   organization of buyer   authorization   noncontravention consents   capitalization valid issuance   buyer sec documents financial statements   no finder  article  actions prior to the closing dates   approval of shareholders   investigation of the medical device business by buyer   preserve accuracy of representations and warranties   third parties governmental approvals   notice of certain matters   conduct of medical device business   conduct of medical device business through the subsequent closing   no solicitation   ocs transfer amount      ii           table of contents continued page     article  additional agreements   taxes   use of names   restrictions on securities lockup clawback   listing   qualifying infringement awards  article  conditions precedent to obligations of buyer   initial closing   subsequent closing  article  conditions precedent to obligations of seller   initial closing   subsequent closing  article  termination   termination   notice of termination   effect of termination  article  indemnification   indemnity   indemnification claims   resolution of conflicts   thirdparty claims   limitations on indemnity   effect of investigation   miscellaneous   exclusive remedy  article  general provisions   confidentiality   no public announcements   notices      iii           table of contents continued page      successors and assigns   access to records after closing date   entire agreement amendments   interpretation   waivers   expenses   payments   partial invalidity   specific enforcement   execution in counterparts   further assurances   governing law   effect of due diligence   no thirdparty beneficiaries   attorneys’ fees        iv           table of contents     exhibits   exhibit a    executed written consent exhibit b    escrow agreement exhibit c    exclusive license agreement exhibit d    seller noncompetition and nonsolicitation agreement exhibit e    transition services agreement       v     asset purchase agreement this asset purchase agreement the “ agreement ” dated as of august   is entered into by and between seaspine holdings corporation a delaware corporation “ buyer ” nlt spine ltd a company organized under the laws of the state of israel  “ seller parent ” and nlt spine inc a delaware corporation “ seller subsidiary ” seller parent and seller subsidiary are collectively referred to herein as “ seller ” and a reference to “seller” herein shall include within it a reference to each of seller parent and seller subsidiary recitals whereas seller owns certain assets in connection with the ownership design development manufacture marketing and commercial exploitation by seller of medical devices which are being developed by seller including without limitation seller’s products designated by seller as “prow fusion” “prow fusionv” “prow fusionl” and “espin”collectively the “ medical device business ” whereas subject to the terms and conditions of this agreement seller desires to sell and buyer desires to buy all of seller’s right title and interest in and to substantially all of the assets used in or necessary for the operation of the medical device business to date whereas prior to or simultaneously with the execution of this agreement in order to induce buyer to enter into this agreement um accelmed limited partnership “ accelmed ” and peregrine as defined in that certain convertible loan agreement dated december   by and among the company accelmed and peregrine as defined therein the “ consenting shareholders ” have delivered to buyer an executed written consent of the consenting shareholders attached hereto as exhibit a the “ executed written consent ” approving among other things this agreement and the transaction contemplated hereby and waiving any rights to block or otherwise prevent the transaction contemplated hereby now therefore in consideration of the premises and the covenants and representations set forth herein and for other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged the parties hereto hereby agree as follows article  definitions         definitions  in this agreement the following terms have the meanings specified or referred to in this section  and shall be equally applicable to both the singular and plural forms any agreement referred to below shall mean such agreement as amended supplemented and modified from time to time to the extent permitted by the applicable provisions thereof and by this agreement “  prow fusionv fda clearance ” means with respect to the  prow fusionv product written notification from the fda that all sizes and configurations within the  prow     certain information on this page has been omitted and filed separately with the securities and exchange commission confidential treatment has been requested with respect to the omitted portions     fusionv product family as such sizes and configurations are specified in the definition of such term and taking into account the tolerance thereto referred to in such term have been cleared to be marketed in the united states under section k of the fdca without conditions or with customary conditions that are commercially reasonable meaning similar in scope to predicate devices “  prow fusionv family ” means the  prow fusionv product with parallel expansion feature having the following specifications for the parallel expansion version i width  ii lordotic options  iii lengths small  medium  and large  and iv height expansion small  medium  and large  and the  prow fusionv product with angular expansion feature having the following specifications i width  ii lordotic options small  medium  and large  iii lengths small  medium  and large  and iv initial height  all the specifications above have a  tolerance buyer and seller may mutually agree to amend the above specifications during the product development process “ aaa ” has the meaning specified in section b  “ additional agreements ” means the initial closing additional agreements and the subsequent closing additional agreements “ affiliate ” means as to any person any other person which is controlling controlled by or under common control with such person for the purposes hereof “control” means the possession directly or indirectly of the power to direct or cause the direction of the affairs or management of a person including without limitation through the ownership of voting securities having the power to elect a majority of the board of directors or other governing body of such person by contract or otherwise “ assignment and assumption agreement ” means an assignment and assumption agreement dated as of the initial closing date by and between buyer and seller in a form mutually acceptable to buyer and seller acting reasonably and in good faith “ assignments of patents ” means those certain assignments of patents dated as of the subsequent closing date by and between buyer and seller in forms for each applicable jurisdiction mutually acceptable to buyer and seller acting reasonably and in good faith “ assumed liabilities ” has the meaning specified in section a  “ business day ” means any day other than friday saturday sunday or such days on which commercial banks in the state of california or tel aviv israel are required or authorized by applicable legal requirements to remain closed “ buyer ” has the meaning specified in the first paragraph of this agreement “ buyer affiliates ” has the meaning specified in section a      certain information on this page has been omitted and filed separately with the securities and exchange commission confidential treatment has been requested with respect to the omitted portions     “ buyer medical device products ” means any medical devices owned designed developed manufactured marketed sold or commercially exploited by buyer its affiliates or their respective authorized licensees that incorporate or exploit the medical device intellectual property “ buyer ocs payment election ” has the meaning specified in section f  “ buyer preferred stock ” has the meaning specified in section   “ buyer sec documents ” has the meaning specified in section a  “ cercla ” means the comprehensive environmental response compensation and liability act of  as amended “ claimed amount ” has the meaning specified in section a  “ claims period ” has the meaning specified in section c  “ closing ” has the meaning specified in section a  “ closing date ” has the meaning specified in section a  “ code ” means the united states internal revenue code of  as amended “ combination product ” means a sale unit which consists of more than one medical product each of which could have been sold independently to the same enduser which are sold as a bundle as one sale unit and at a bundled price which relates to the entire sale unit provided that at least one of such medical products is an interbody product or a noninterbody product and at least one of such medical products is not an interbody product or a noninterbody product “ common stock ” means the common stock of buyer  par value per share “ confidentiality agreement ” means that certain mutual nondisclosure agreement dated as of november   by and between buyer and seller “ consenting shareholders ” has the meaning specified in the recitals to this agreement “ contingent asset purchase payment ” and “ contingent asset purchase payments ” have the meanings specified in section a  “ credits ” means the amount of i all royalties or other similar payments payable by buyer or any of its affiliates to any consultant or advisor of the seller including without limitation any royalties that may be payable to  andor  it being understood for further clarity that solely to the extent that such liabilities are not taken as credits by buyer any all liabilities under any such consulting agreements or arrangements are retained liabilities hereunder provided that any royalties or similar payments which are payable as a result of any agreement of buyer or an affiliate of buyer shall not be taken into     certain information on this page has been omitted and filed separately with the securities and exchange commission confidential treatment has been requested with respect to the omitted portions     account for purposes of this clause i and ii  of all royalties or other similar payment amounts paid to third parties by buyer for buyer to acquire thirdparty licenses or other similar rights which are necessary in order for buyer or its affiliates to own manufacture market or commercially exploit any current products without taking into account any modifications enhancements or improvements thereto without infringing rights held by such third party “ current products ” means each of “prow fusion” “prow fusionv” “prow fusionl” and “espin” in each case in the versions that have been cleared by the fda or are pending in the sellers applicable updated filings under section k of the fdca as of the date hereof “ deflection mechanism device” means each of i a discectomy or tissue grinder device comprised of a deflectable tip which device implements a deflection and tissue grinding principle which is similar in design and function to the deflection and tissue grinding principle which is implemented in the espin device by way of nonlimiting example see us patent  or ii a segmented implantable device inserted along a rigid guide and then deflected so as to follow a predefined path provided that such segmented implantable device implements a deflection principle which is similar in design and function to the deflection principle which is implemented in the prow fusion device  by way of nonlimiting example see us patent   “ encumbrance ” means any lien claim charge security interest mortgage pledge easement conditional sale or other title retention agreement defect in title covenant or other third party rights or thirdparty restrictions of any kind “ environmental and safety requirements ” means all federal state local and foreign statutes regulations ordinances and other provisions having the force or effect of law all judicial and administrative orders and determinations all contractual obligations and all common law in each case concerning public health and safety worker health and safety pollution or protection of the environment including without limitation all those relating to the presence use production generation handling transport treatment storage disposal distribution labeling testing processing discharge release threatened release control or cleanup of any hazardous or otherwise regulated materials substances or wastes chemical substances or mixtures pesticides pollutants contaminants toxic chemicals petroleum products or byproducts asbestos polychlorinated biphenyls noise radiation or radon each as amended and as now or hereafter in effect “ environmental lien ” means any lien whether recorded or unrecorded in favor of any governmental body relating to any liability of seller arising under any environmental and safety requirements “ escrow agent ” means esop management and trust services ltd  “ escrow agreement ” means that certain escrow agreement dated prior to or as of the shares issuance date by and among buyer seller and the escrow agent in substantially the form attached hereto as exhibit b  “ exchange act ” means the securities exchange act of  as amended        “ excluded assets ” has the meaning specified in section   “ excluded intellectual property ” means all of the following intellectual property used in the excluded operations except for intellectual property that is included in the purchased assets a inventions whether or not patentable whether or not reduced to practice and whether or not yet made the subject of a pending patent application or applications b ideas and conceptions of patentable subject matter including without limitation any patent disclosures whether or not made the subject of a pending patent application or applications c all worldwide statutory invention registrations patents patent registrations and patent applications including all reissues divisions continuations continuationsinpart extensions and reexaminations and all rights therein provided by law multinational treaties or conventions and all improvements to the inventions disclosed in each such registration patent or application d trademarks service marks trade dress logos trade names and corporate names including all of the goodwill associated therewith whether or not registered including all common law rights and registrations and applications for registration thereof e copyrights whether or not registered and registrations and applications for registration thereof and all rights therein provided by law multinational treaties or conventions f trade secrets and confidential technical information including confidential ideas formulas compositions inventions and conceptions of inventions whether patentable or unpatentable g technology including know‑how and show‑how manufacturing and production processes and techniques research and development information drawings specifications designs plans proposals technical data and copyrightable works whether secret or confidential or not h copies and all tangible embodiments of all of the foregoing in whatever form or medium i all rights to obtain and rights to apply for patents and to register trademarks and copyrights inter alia  for any of the intellectual property rights listed or described above and j all rights to sue for and recover and retain damages costs or attorneys’ fees for present and past infringement of any of the intellectual property rights described above “ excluded operations ” means the ownership design development manufacture marketing and commercial exploitation by seller of products other than medical device products “ exclusive license agreement ” means that certain exclusive license agreement dated as of the initial closing date by and between buyer and seller in substantially the form attached hereto as exhibit c  “ executed written consent ” has the meaning specified in the recitals to this agreement “ expansion mechanism device ” means any of i an implantable device formed from a base interconnected at hinges with a sequence of segments wherein a the device is inserted in a low profile state with the sequence of segments substantially closed against the base b the base is then shortened shortening a distance between the ends of the sequence of segments thereby deflecting at least part of the sequence of segments to move away from or increase an angle relative to the base and c the device implements an expansion principle which is similar in design and function to the expansion principle which is implemented in the prow fusionv          device  by way of nonlimiting example see us patent  or pct application wo ii an implantable device comprising a constant length backbone connected to one or more deflectable pieces and an angular expansion mechanism that increases an angle between the backbone and the deflectable pieces wherein the device implements an expansion principle which is similar in design and function to the expansion principle which is implemented in the prow fusionl device  by way of nonlimiting example see pct application wo  iii an expansion mechanism based on pinandslots or rotating cams as depicted in us patent application no  and iv an implantable device inserted into a patients body as a closed loop and opened inside the patients body to form an enclosed volume   as depicted in us patents  and  “ fcpa ” has the meaning specified in section b  “ fda ” means the united states food and drug administration “ fda clearances ” means each of the prow fusionl fda clearance and the mm prow fusionv fda clearance “ fdca ” means the food drug and cosmetic act  usc §  et seq  “ financial statements ” has the meaning specified in section   “ first interbody commercialization date ” shall mean the date of consummation of the first bona fide commercial sale including alpha sales by buyer or an affiliate thereof to a nonaffiliate of any interbody product  “ first noninterbody commercialization date ” shall mean the date of consummation of the first bona fide commercial sale including alpha sales by buyer or an affiliate thereof to a nonaffiliate of any noninterbody product “ first milestone ” means the  successful implantation of a “prow fusionv” product within the prow fusionv product family “ first milestone payment ” has the meaning specified in section a  “ fourth milestone ” means the later to occur of i the  successful implantation of a product within the prow fusionv product family and ii the  successful implantation of a product within the prow fusionl product family “ fourth milestone payment ” has the meaning specified in section d  “ fundamental representations ” has the meaning specified in section   “ gaap ” means the united states generally accepted accounting principles          “ governmental body ” means any foreign national federal state county local or district governmental body public authority or public agency or any other political subdivision public corporation or governmental or regulatory authority of the foregoing whether foreign or domestic “ governmental grant ” means any grant incentive subsidy award loan participation exemption status cost sharing arrangement reimbursement arrangement or other benefit relief or privilege provided or made available by or on behalf of or under the authority of the ocs the investment center of the ministry of the economy and industry the israel tax authority solely with respect to “benefit” or “approved” enterprise status or similar programs the state of israel and any other bi or multinational grant program framework or foundation including the bird foundation for research and development the european union the fund for encouragement of marketing activities of the israeli government or any other governmental body “ governmental order ” means any judgment order award or decree of any foreign national federal state local or other court or tribunal or any governmental body and any award in any arbitration proceeding “ governmental permits ” has the meaning specified in section a  “ healthcare laws ” has the meaning specified in section b  “ healthcare regulatory agency ” has the meaning specified in section a  “ healthcare regulatory permits ” has the meaning specified in section a  “ hipaa ” has the meaning specified in section b  “ imh ” means the israeli ministry of health “ indebtedness ” means with respect to any person any indebtedness secured or unsecured a in respect of borrowed money whether or not the recourse of the lender is to the whole of the assets of such person or only to a portion thereof and evidenced by bonds notes debentures or similar instruments or letters of credit to the extent of the face value thereof or in the case of evidence of indebtedness issued at a discount the current accredit value thereof or b representing the balance deferred and unpaid of the purchase price of property or services other than accounts payable including trade payables in the ordinary course of business and shall also include to the extent not otherwise included i any capitalized lease obligations and ii the face value of guaranties of items of other persons which would be included within this definition for such other persons whether or not such items would appear upon the balance sheet of the guarantor “ indemnified person ” has the meaning specified in section a  “ indemnifying person ” has the meaning specified in section a  “ infringement award ” has the meaning specified in section    “ initial closing ” has the meaning specified in section a           “ initial closing additional agreements ” means all agreements including exhibits instruments and documents being or to be executed and delivered under this agreement or in connection herewith at the initial closing including but not limited to the following i the assignment and assumption agreement ii the initial closing bill of sale iii the seller noncompetition and nonsolicitation agreement iv the exclusive license agreement and v the transition services agreement “ initial closing bill of sale ” means a bill of sale dated as of the initial closing date by and between buyer and seller relating to the sale of certain of the purchased assets at the initial closing in a form mutually acceptable to buyer and seller acting reasonably and in good faith “ initial closing cash consideration ” has the meaning specified in section a “ initial closing purchased assets ” means all the purchased assets other than medical device intellectual property “ initial closing date ” has the meaning specified in section a  “ integrated technology product ” means an interbody product or noninterbody product that incorporates intellectual property regarding which in exchange for the right to use buyer or an affiliate of buyer is obligated to pay to a third party a license royalty milestone or other payment   “ interbody product ” means an interbody expandable or deflectable buyer medical device product that i is an expansion mechanism device or a deflection mechanism device or ii is subject at the time of the applicable sale of such buyer medical device product to a claim of one or more thencurrently issued unexpired patents included in the purchased assets including a patent which was in the application phase on the date of this agreement and which was issued at any time thereafter and which has not been finally revoked or held unenforceable or invalid by a decision of a court of governmental body or competent jurisdiction from which no appeal can be taken or with respect to which an appeal is not taken within the time allowed for appeal and which has not been disclaimed denied or admitted to be invalid or unenforceable through reissue or disclaimer and which has not been lost through an interference proceeding or by abandonment it being understood that a buyer medical device product shall be deemed “subject to a claim”   “ international trade law ” means us israeli and other applicable jurisdictions’ statutes laws and regulations applicable to international transactions including the export administration act the export administration regulations the arms export control act the international traffic in arms regulations the international emergency economic powers act the trading with the enemy act us customs laws and regulations the foreign asset control regulations or the israeli trade with the enemy ordinance  law governing the control of commodities and services  order regarding the engagement in encryption          items  as amended declaration governing the control of commodities and services engagement in encryption items  as amended import and export order control of dualpurpose goods services and technology exports  and any regulations or orders issued thereunder “ irs ” means the internal revenue service of the united states of america “ knowledge of seller ” “ seller’s knowledge ” or similar terms means the actual knowledge of a particular fact or other matter by each of the individuals set forth on schedule a after reasonable inquiry including the reasonable inquiry of such individual’s direct reports “ legal requirements ” means all foreign national federal state and local laws statutes regulations rules codes ordinances enforceable judgments injunctions decrees orders permits approvals treaties enacted adopted issued or promulgated by any governmental body including without limitation those pertaining to electrical building zoning environmental and occupational safety and health requirements and common law “ losses ” has the meaning specified in section a  “ material adverse effect ” means any change circumstance or effect that individually or in the aggregate with all other changes circumstances and effects has or is reasonably likely to have a material adverse effect on i the purchased assets or ii the medical device business or any change circumstance or effect that would prevent or materially delay the ability of seller to consummate the transactions contemplated by this agreement provided  however  that no change circumstance or effect resulting or arising from any of the following shall constitute a material adverse effect or shall be taken into account when determining whether a material adverse effect exists has occurred or would reasonably be likely to exist or occur a any changes in general united states or general israeli economic conditions b conditions or changes therein in the medical device industry c general legal economic political andor regulatory conditions or changes therein in the united states or israel including any changes affecting financial credit or capital market conditions in the united states or israel d any change in gaap or interpretation thereof e any adoption implementation promulgation repeal modification amendment reinterpretation change or proposal of any applicable legal requirements of or by any governmental body f the execution of and compliance with the terms of this agreement or g any action consented to in writing by buyer provided  however  in the case of any of clauses a b c d and e such changes circumstances or effects may be taken into account to the extent that such changes circumstances or effects disproportionately impact seller relative to other similarly situated companies operating in the medical device industry “ medical device business ” has the meaning specified in the recitals to this agreement “ medical device intellectual property ” means all of the intellectual property used by seller it being clarified that other that with respect to the intellectual property that is the subject of the  any intellectual property developed or invented by or licensed to seller shall be deemed “used” by seller or held for use in the medical device business including without limitation to the extent used in the medical device business each of the following a inventions which are not in        the public domain whether or not patentable and whether or not yet made the subject of a pending patent application or applications b ideas and conceptions of patentable subject matter including without limitation any patent disclosures whether or not made the subject of a pending patent application or applications c all worldwide statutory invention registrations patents patent registrations and patent applications including all reissues divisions continuations continuationsinpart extensions and reexaminations and all rights therein provided by law multinational treaties or conventions and all improvements to the inventions disclosed in each such registration patent or application collectively “ patents ” d trademarks service marks trade dress logos trade names and corporate names including any and all rights to the names “prow fusion” “prow fusionv” “prow fusionl” and “espin” including all of the goodwill associated therewith whether or not registered including all common law rights and registrations and applications for registration thereof collectively “ trademarks ” e copyrights whether or not registered and registrations and applications for registration thereof and all rights therein provided by law multinational treaties or conventions collectively “ copyrights ” f trade secrets and confidential technical information including confidential ideas formulas compositions inventions and conceptions of inventions whether patentable or unpatentable collectively “ trade secrets ” g technology including know‑how and show‑how manufacturing and production processes and techniques research and development information drawings specifications designs plans proposals technical data and copyrightable works whether secret or confidential or not “ knowhow ” h copies and all tangible embodiments of all of the foregoing in whatever form or medium i all rights to obtain and rights to apply for patents and to register trademarks and copyrights inter alia  for any of the intellectual property rights described above and j all rights to sue for and recover and retain damages costs or attorneys’ fees for present and past infringement of any of the intellectual property rights listed or described above “medical device products ” means any medical devices owned designed developed manufactured marketed or commercially exploited by seller that incorporate or exploit medical device intellectual property “ milestone payments ” has the meaning specified in section a  “ milestone shares ” has the meaning specified in section e  “ net sales ” means the total amount actually received by buyer or any of its affiliates with respect to sales of interbody products or noninterbody products by buyer or any of its affiliates or their respective authorized licensees as the case may be to nonaffiliate third parties less deduction of all of the following to the extent applicable to such sales a all commissions payable in connection therewith including without limitation commissions payable to buyer’s and its affiliates’ sales personnel and sales representatives other than sales personnel acting in a sales management capacity eg area vice presidents and regional business managers and distributors b all trade and quantity credits charge backs from wholesalers or discounts to the extent such amounts are included in the original gross receipts whether or not such amounts have been separately itemized as a part of the original gross receipts c all amounts of freight insurance and other freight expenses included in any invoice d all allowances or credits for returns or rejected interbody products or noninterbody products to the extent such amounts are included in the original gross          receipts e all import export excise sales value added and use taxes custom duties freight and insurance to the extent such amounts are included in the original gross receipts or are otherwise paid by buyer and f all adjustments allowances credits reimbursements chargeback payments and rebates or the equivalent thereof granted to group purchasing organizations or other buying groups managed health care organizations health maintenance organizations or any other providers of health insurance coverage health care institutions including hospitals or other health care organizations or to foreign national federal stateprovincial local and other governments including their agencies or to wholesalers distributors or other trade customers for interbody products or noninterbody products in each case to the extent such amounts are included in the original gross receipts whether or not such amounts have been separately itemized as a part of the original gross receipts if an interbody product or noninterbody product is sold as part of a combination product the net sales for such interbody product or noninterbody product for the purpose of calculating contingent asset purchase payments owed under this agreement shall be determined as follows buyer shall determine the actual net sales of such combination product and then such amount shall be multiplied by the fraction aab where “a” is the then current invoice price of such interbody product or noninterbody product if sold separately and “b” is the aggregate invoice price for each other device or product in the combination product if sold separately if the other device or product in the combination product is not sold separately net sales shall be calculated by multiplying actual net sales of such combination product by a fraction ac where “a” is the then current invoice price of interbody product or noninterbody product if sold separately and “c” is the invoice price of the combination product if neither the interbody product or noninterbody product nor the other device or product is sold separately the adjustment to net sales shall be determined by buyer and seller together after a good faith conversation to reasonably reflect the fair market value of the contribution of such interbody product or noninterbody product in the combination product to the total fair market value of such combination product if buyer and seller are unable to reach an agreement the parties shall jointly appoint a third party expert from one of the big four accounting firms that has not worked within the last five years with either of buyer or seller to determine the adjustment that should be made to net sales in such a case each party shall submit a proposal to such third party expert and the third party experts decision shall be within the range determined by such proposals the parties shall split the cost of the third party expert provided that if the third party experts final decision is not within  of a partys proposal and is within  of the other party’s proposal such party shall bear the full cost of such third party expert with respect to integrated technology products if buyer or an affiliate of buyer acquired from a third party the right whether by license or otherwise to use any patents or knowhow incorporated in an integrated technology product a “ third party license ” then buyer shall deduct from net sales attributable to such integrated technology product an amount equal to fifty percent  of license milestone royalty andor other payments made when due and payable by buyer under such third party license notwithstanding the foregoing in no event shall any such deduction of net sales attributable to such integrated technology product reduce the amount payable as a contingent asset purchase payment to seller at any payment          date by more than  of the net sales upon which such contingent asset purchase payment is calculated “ noninterbody products ” means any buyer medical device product that is not an interbody product and that is partially or fully developed following the initial closing “ nonus person ” has the meaning specified in section d  “ ocs ” means as applicable the innovation authority and office of chief scientist as applicable of the ministry of economy of the state of israel and affiliated authorities or programs including without limitation the incubator administration tnufa nofar magnet and magneton “ ocs conditional approval ” means a written approvalruling from the ocs conditionally approving the transfer by seller of the ocs financed ip and any rights thereto outside of israel to inter alia  buyer within twelve  months after the date thereof or within eighteen  months after the date thereof pursuant to any amendment to such conditional approval effected in accordance with section b  upon payment of the ocs transfer amount free of any encumbrances and other restrictions and conditions other than the payment of the ocs transfer amount “ ocs financed ip ” means any medical device intellectual property which is subject to the law for the encouragement of research and development and technological innovation in industry  as amended “ ocs preliminary conditional approval ” means a written approvalruling from the ocs in response to a request made by seller parent to which the exclusive license agreement will be attached whereby the ocs approves seller parent’s request to permit buyer to manufacture distribute and market medical device products which incorporate ocs financed ip outside of israel as contemplated in the exclusive license agreement   “ ocs transfer amount ” means an amount payable by seller parent to the ocs as set forth in the ocs conditional approval in order to permit the seller parent to lawfully transfer the ocs financed ip and any rights thereto outside of israel provided that the ocs conditional approval shall provide that such amount shall equal the aggregate sum of funding provided by the ocs to seller parent to date including funding provided through the ocs incubator program in which the seller parent participated which sum after deducting amounts repaid to the ocs to date equals approximately  plus interest accrued thereon after july   it being clarified that such interest shall continue to accrue until the date on which the ocs transfer amount is paid to the ocs the breakdown of the sums comprising the ocs transfer amount and the respective interest rates which are applicable thereto are set forth on schedule b  “ ocs transfer amount payment deadline ” means the deadline for payment of the ocs transfer amount as set forth in the ocs conditional approval or any amendment to such ocs conditional approval effected in accordance with section b  or as otherwise set by the ocs in the ocs conditional approval              “ officer’s certificate ” has the meaning specified in section a  “ participation notice ” has the meaning specified in section    “ participation share ” has the meaning specified in section   “ permitted encumbrances ” means a liens for taxes and other governmental charges and assessments which are not yet due and payable b liens of landlords and liens of carriers warehousemen suppliers mechanics and materialmen and other like liens arising as a matter of law or in the ordinary course of business for sums not yet due and payable and c negative pledges which do not impair the transfer of the purchased assets and which would not apply to buyer or the purchased assets after the applicable closing “ person ” means any individual corporation partnership limited liability company joint venture association joint stock company trust unincorporated organization governmental body or any other entity “ prow fusionl fda clearance ” means with respect to the prow fusionl product written notification from the fda that all sizes and configurations intended for a lateral procedure within the prow fusionl product family have been cleared to be marketed in the united states under section k of the fdca without conditions or with customary conditions that are commercially reasonable meaning similar in scope to predicate devices it being understood that ll would necessarily be a commercially reasonable intended use condition for the prow fusionl lateral procedure “ prow fusionl product family ” means the prow fusionl product having the following specifications  i lengths  ii heights  iii lordotic options  and iv width expansion  or  all the specifications above have a  tolerance buyer and seller may mutually agree to amend the above specifications during the product development process “ prow fusionv fda clearance ” means with respect to the prow fusionv product the written notification from the fda dated july   a full and complete copy which has been provided to buyer “ prow fusionv product family ” means the each of the following prow fusionv products having the following specifications i prow fusionv parallel expansion having the following specifications a width  b lordotic options   c lengths small  medium  and large  d height expansion small  medium  and large  and ii prow fusionv angular lordosis expansion having the following specifications a width  b lengths small  medium  and large  and c angular expansion  height   height   height  all the specifications above have a  tolerance buyer and seller may mutually agree to amend the above specifications during the product development process            “ purchase price allocation ” has the meaning specified in section   “ purchased assets ” has the meaning specified in section   “ qualifying infringement award ” has the meaning specified in section   “ records ” has the meaning specified in section c  “ reference market value ” means the volume weighted average closing sale price of a share of common stock on the nasdaq global select market for the  consecutive trading day period ending one  trading day prior to the applicable reference date “ release ” has the meaning specified in cercla “ remaining assets ” has the meaning specified in section b  “ required shareholder ” has the meaning specified in the recitals to this agreement “ restricted period ” has the meaning specified in section biv  “ retained liabilities ” has the meaning specified in section b  “ schedules ” has the meaning specified in the introductory paragraph to article   “ sec ” means the united states securities and exchange commission “ second milestone ” means  successful implantation of a “prow fusionl” product within the prow fusionl product family “ second milestone payment ” has the meaning specified in section b  “ securities act ” means the united states securities act of  as amended “ seller ” has the meaning specified in the first paragraph of this agreement “ seller affiliates ” has the meaning specified in section b  “ seller noncompetition and nonsolicitation agreement ” means that certain noncompetition and nonsolicitation agreement dated as of the initial closing date by and between buyer and seller in substantially the form attached hereto as exhibit d  “ seller parent ” has the meaning specified in the first paragraph of this agreement “ seller subsidiary ” has the meaning specified in the first paragraph of this agreement “ setoff rights ” has the meaning specified in section b  “ shares ” has the meaning specified in section bi           “ shares issuance date ” has the meaning specified in section b  “ shares issuance date reference market value ” means the volume weighted average closing sale price of a share of common stock on the nasdaq global select market for the twenty  consecutive trading day period ending one  trading day prior to the shares issuance date provided  however  after the computation thereof if such volume weighted average closing sale price is i less than  per share of common stock then the “shares issuance date reference market value” shall be  per share of common stock or ii greater than  per share of common stock then the “shares issuance date reference market value” shall be  per share of common stock “ special representations ” has the meaning specified in section   “ subsequent closing ” has the meaning specified in section a  “ subsequent closing additional agreements ” means all agreements including exhibits instruments and documents being or to be executed and delivered under this agreement or in connection herewith at the subsequent closing including but not limited to the following i the assignments of patents and ii the subsequent closing bill of sale each in a form mutually acceptable to buyer and seller acting reasonably and in good faith  “ subsequent closing bill of sale ” means that certain bill of sale dated as of the subsequent closing date by and between buyer and seller relating to the sale of certain of the purchased assets at the subsequent closing in a form mutually acceptable to buyer and seller acting reasonably and in good faith “ subsequent closing date ” has the meaning specified in section a  “ successful ” means with respect to the implantation of a medical device a the effective insertion expansion and release of such device including effective removal of such device within the same surgical procedure if such removal is determined by surgical personnel to be warranted and b without a nonexpected devicerelated serious adverse event or product breakage or failure during the “postoperative period”  for purposes of this definition “postoperative period” means the earlier of   following the surgery in which such medical device was implanted and  with respect to a the first milestone the date on which the “n” th  implantation of a prow fusionv product within the prow fusionv product family is performed where “n” equals the sum of  and the number of such implantations that did not satisfy clause a above or as of such date clause b above b the second milestone the date on which the “n” th implantation of a prow fusionl product within the prow fusionl product family is performed where “n” equals the sum of  and the number of such implantations that did not satisfy clause a above or as of such date clause b above and c the fourth milestone the latter to occur of i the date on which the “n” th implantation of a product within the prow fusionv product family is performed where “n” equals the sum of  and the number of such implantations that did not satisfy clause a above or as of such date clause b above and ii the date on which the “n” th implantation of a product within the prow fusionl product family is performed where “n” equals the sum of  and          the number of such implantations that did not satisfy clause a above or as of such date clause b above “ tax ” means i any national federal state local or foreign income alternative or add‑on minimum gross income gross receipts property sales use transfer value added gains license excise employment payroll withholding or minimum tax or any other tax custom duty governmental fee or other like assessment or charge of any kind whatsoever together with any interest or any penalty addition to tax or additional amount imposed by any governmental body or ii any liability for amounts referred to in i as a result of any obligations to indemnify another person or as a result of being a successor in interest or transferee of another person “ tax return ” means any return report or similar statement required to be filed with respect to any taxes including any attached schedules including without limitation any information return claim for refund amended return and declaration of estimated tax “ third milestone ” means the  implantation of a product within the  prow fusionv product family “ third milestone payment ” has the meaning specified in section c  “ third party claim ” has the meaning specified in section a  “ third party expenses ” has the meaning specified in section   “ transfer taxes ” has the meaning specified in section   “ transferred permits ” has the meaning specified in section d  “ transition services agreement ” means that certain transition services agreement dated as of the initial closing date and to become effective as of the shares issuance date by and between buyer and seller in substantially the form attached hereto as exhibit e  “ uncitral arbitration rules ” has the meaning specified in section a  “ united states ” has the meaning specified in section c  “ us person ” has the meaning specified in section c  “ valid certificate ” has the meaning specified in section   “ valid claim ” means a claim of any currently issued unexpired patent or current patent application that has not been pending for more than  – in each case  included in the purchased assets and that has not been finally rejected revoked or held unenforceable or invalid prior to the shares issuance date by a decision of a court or governmental body or competent jurisdiction from which no appeal can be taken or with respect to which an appeal is not taken within the time allowed for appeal and that has not been disclaimed denied or admitted to be invalid or unenforceable          through reissue or disclaimer prior to the shares issuance date and that has not been lost through an interference proceeding or by abandonment prior to the shares issuance date provided however that the claims of any patent applications which are assigned back from buyer to seller parent without consideration prior to the  anniversary of the shares issuance date shall not be deemed “valid claims” from the time of such assignment and at all times thereafter       interpretation  a      when a reference is made in this agreement to a section schedule or exhibit such reference shall be to a section of or schedule or exhibit to this agreement unless otherwise indicated b      the headings contained in this agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this agreement c      the words “include” “includes” and “including” when used herein shall be deemed in each case to be followed by the words “without limitation” d      the phrases “delivered” “provided to” “made available” and “furnished to” and phrases of similar import when used herein unless the context otherwise requires means with respect to any statement in article  of this agreement to the effect that any information document or other material has been “delivered” “provided to” or “furnished” to buyer that such information document or material was i made available for review without subsequent modification by seller by buyer in the virtual data room set up by seller in connection with this agreement and located at  at least two  business days prior to the date of this agreement or ii actually delivered whether by physical or electronic delivery to buyer at least two  business days prior to the date of this agreement e      unless the context of this agreement otherwise requires i words of any gender include each other gender ii words using the singular or plural number also include the plural or singular number respectively and iii the terms “hereof” “herein” “hereunder” and derivative or similar words refer to this entire agreement article    purchase and sale         purchase and sale  on the terms and subject to the conditions of this agreement at the applicable closing seller shall sell convey assign transfer and deliver to buyer or buyer’s designee and buyer or buyer’s designee shall purchase and accept from seller all right title and interest of seller in and to substantially all of the tangible and intangible properties rights and assets owned or held by seller and relating to or used or held for use in connection with the medical device business collectively the “ purchased assets ” free and clear of all encumbrances except          for permitted encumbrances including without limitation the following assets but excluding the excluded assets            a      all medical device intellectual property including without limitation the intellectual property set forth on schedule a and any and all rights to the names “prow fusion” “prow fusionv” “prow fusionl” and “espin” and any other names used by seller in the sales and marketing materials or on the medical device products however labeled b      all of seller’s rights regarding ownership design development manufacture marketing and commercial exploitation of medical device products c      all technical drawings blueprints assembly drawings design master records and design history files including all engineering testing and risk assessment records device history files and records product specifications including engineering drawings product labeling and inspection documentation summary technical documents and technical files for prior or existing registrations documentation and correspondence verifications and validations medical device reports complaint files quality system documentation including lot records and associated nonconformance records rework and deviation records service history files corrective and preventive actions internal audit reports supplier lists supplier management files customer lists pricing lists books ledgers correspondence repair and maintenance records operation manuals advertising promotional and marketing materials including without limitation catalogues brochures trade show equipment field inventory loaners sales force inventory and consignments and any other information or documentation relating to the medical device business collectively the “ records ” d      all licenses permits approvals registration approval certificates variances waivers or consents issued by any governmental body used in or necessary to the operation of the medical device business as conducted to date as set forth on schedule d collectively the “ transferred permits ” e      all documents sent to or received from the fda and any foreign counterpart relating to medical device products including without limitation submissions and amendments clearances received acknowledgment letters audits and warning letters file submissions to other countries and other similar documentation f      all data studies reports and publications relating to medical device products that have been completed are in process or are being formulated or collected by the seller as of the initial closing date g      to the extent assignable without the need to receive the consent of the applicable employees third parties and suppliers all rights claims and benefits of seller in to or under any i a employee confidentiality agreements entered into by seller and b confidentiality or secrecy agreements entered into by seller with third parties that relate to the use or disclosure of information concerning the purchased assets or the medical device business and ii express or implied warranties from the suppliers of goods or services including any coverage rights under product liability or other insurance maintained by any of such suppliers for the benefit of seller     certain information on this page has been omitted and filed separately with the securities and exchange commission confidential treatment has been requested with respect to the omitted portions     h      the goodwill and going concern value of the medical device business and i      all other assets properties and rights of seller of every kind associated with the medical device business whether tangible or intangible and wherever situated other than the excluded assets       assets not to be transferred  seller shall retain and buyer shall not acquire the following assets and properties of seller which together shall constitute the “ excluded assets ” a      all cash bank deposits and cash equivalents of seller b      the excluded intellectual property including the intellectual property that is the subject of the siegal agreement c      all rights and interests in real property including any and all real property leases d      all contracts including without limitation the license agreement entered into by and between the seller and  on february   the “  ” e      all rights in connection with and assets in any employee benefit plan f      all physical assets or tangible personal property g      all rights under insurance policies of seller and h      all right title and interest of seller in and to all of the tangible and intangible properties rights and assets other than the purchased assets that are owned or held by seller and relate to or are used or held for use in connection with the excluded operations       liabilities and obligations  a      on the initial closing date buyer shall accept assume and agree to pay perform or otherwise discharge in accordance with the respective terms and subject to the respective conditions thereof and hereof only those liabilities set forth on schedule  the “ assumed liabilities ” b      except as expressly set forth in section a  buyer shall not assume or have any responsibility for any liability obligation or commitment of any nature of seller whether now or hereafter existing known or unknown accrued or unaccrued or due to come due including without limitation those liabilities and obligations specifically identified as “retained liabilities” throughout this agreement herein collectively the “ retained liabilities ” seller acknowledges and agrees that it shall be fully responsible for all such retained liabilities the parties agree that notwithstanding the disclosure of a liability on a schedule hereto other than schedule   such liability shall constitute a retained liability unless it is explicitly set forth on schedule   for further clarity it is expressly understood and agreed that the ocs transfer amount shall be a retained liability     certain information on this page has been omitted and filed separately with the securities and exchange commission confidential treatment has been requested with respect to the omitted portions           consideration  in consideration for the purchased assets and the seller’s entry into the exclusive license agreement buyer shall pay or do the following a      at the initial closing buyer shall pay to seller  in cash by wire transfer of immediately available funds to such account as seller shall designate in writing to buyer the “ initial closing cash consideration ” b      provided that i the initial closing has occurred ii seller has provided an officer’s certificate executed by the chief executive officer of seller stating that each of the representations and warranties of seller contained herein with respect to the purchased assets to be transferred at the subsequent closing a qualified by materiality or material adverse effect is true and correct in all respects on the shares issuance date and b not qualified by materiality or material adverse effect is true and correct in all material respects on the shares issuance date as though made on the shares issuance date iii all consents and approvals of the nasdaq global select market of the listing of the shares on the nasdaq global select market have been obtained iv seller has provided buyer with the escrow agreement executed by seller and the escrow agent v seller and the escrow agent have confirmed in writing that all documents required to be placed in escrow under the escrow agreement have been deposited in escrow with the escrow agent under the escrow agreement and the seller has confirmed in writing that such documents have been duly executed vi seller has provided buyer with access to complete and accurate copies of all applications registrations agreements and other documents referenced in schedule a in electronic format that are not publicly available documents vii a bill of sale dated as of the shares issuance date by and between buyer and seller relating to the sale of the transferred permit referenced as item  in schedule e  in a form mutually acceptable to buyer and seller acting reasonably and in good faith viii evidence satisfactory to buyer of the making of any notice filings required to be made with the fda or other governmental body or person in respect of the medical device product referenced in item  in schedule e  within five  business days following the later to occur of such later date the “ shares issuance date ” x the effective date of the prow fusionl fda clearance and y the date of issuance by the ocs of the ocs conditional approval i      buyer shall subject to section   issue to seller that number of shares of common stock as is equal to the quotient obtained by dividing x  by y the shares issuance date reference market value the “ shares ” with any fraction of a share being rounded down to the next whole share       milestone payments  subject to the setoff rights in the event that the initial closing is consummated as additional consideration for the purchased assets buyer shall make certain contingent milestone payments collectively the “ milestone payments ” to seller on the terms provided in this section   a      in the event that the first milestone is completed buyer shall make a payment the “ first milestone payment ” to seller at buyer’s sole election of either i  in cash or ii that number of shares of common stock equal to the quotient obtained     certain information on this page has been omitted and filed separately with the securities and exchange commission confidential treatment has been requested with respect to the omitted portions     by dividing x  by y the reference market value on the date of payment with any fraction of a share of common stock being rounded down to the next whole share the first milestone payment shall be paid by buyer within thirty  days following completion of the first milestone b      in the event that the second milestone is completed buyer shall make a payment the “ second milestone payment ” to seller at buyer’s sole election of either i  in cash or ii that number of shares of common stock equal to the quotient obtained by dividing x  by y the reference market value on the date of payment with any fraction of a share of common stock being rounded down to the next whole share the second milestone payment shall be paid by buyer on the thirtieth day following completion of the second milestone c      in the event that the third milestone is completed buyer shall make a payment the “ third milestone payment ” to seller at buyer’s sole election of either i  in cash or ii that number of shares of common stock equal to the quotient obtained by dividing x  by y the reference market value on the date of payment with any fraction of a share of common stock being rounded down to the next whole share the third milestone payment shall be paid by buyer on the thirtieth day following completion of the third milestone d      in the event that the fourth milestone is completed buyer shall make a payment the “ fourth milestone payment ” to seller at buyer’s sole election of either i  in cash or ii that number of shares of common stock equal to the quotient obtained by dividing x  by y the reference market value on the date of payment with any fraction of a share of common stock being rounded down to the next whole share the fourth milestone payment shall be paid by buyer on the thirtieth day following completion of the fourth milestone       contingent asset purchase payments  a      subject to the setoff rights and the limitations set forth in section d  in the event that the initial closing is consummated as additional consideration for the purchased assets buyer shall also pay to seller subject to the terms of this section   contingent asset purchase payments based on net sales less any credits as follows each a “ contingent asset purchase payment ” and collectively “ contingent asset purchase payments ” i      during the period commencing on the first interbody commercialization date and ending on the   anniversary of the first interbody commercialization date an amount equal to  percent  of net sales in such period of any and all interbody products ii      during the period commencing on the day after the   anniversary of the first interbody commercialization date and ending on the   anniversary of the first interbody commercialization date an amount equal to  percent  of net sales in such period of any and all interbody products     certain information on this page has been omitted and filed separately with the securities and exchange commission confidential treatment has been requested with respect to the omitted portions     iii      during the period from and after the day after the   anniversary of the first interbody commercialization date and ending upon the satisfaction of either of the conditions set forth in section d  an amount equal to  percent  of net sales in such period of any and all interbody products and iv      during the period commencing on the first noninterbody commercialization date and ending upon the satisfaction of either of the conditions set forth in section d  an amount equal to  percent  of net sales in such period of any and all noninterbody products that are subject to valid claims   b      buyer shall pay the contingent asset purchase payments set forth in section a within sixty  days following each calendar quarter which ends following the first interbody commercialization date with respect to interbody products or first noninterbody commercialization date with respect to noninterbody products for net sales in the previous calendar quarter period each contingent asset purchase payment under this section  shall be accompanied by a statement of the amount of net sales during the applicable period and such other information as is necessary to determine the amount of the payments to be made to seller hereunder all contingent asset purchase payments payable to seller shall be paid in us dollars net sales shall first be calculated in the currency in which the sales were made and then directly converted into us dollars at the exchange rate reported in the us edition of the wall street journal or other publication chosen by the parties by mutual written consent from time to time for the last business day of the period for which such payment is due to seller under this agreement c      buyer shall provide to seller  written updates with respect to its progress towards completing the milestones and shall keep and shall ensure that its affiliates keep full and accurate books and records of all items necessary to correctly calculate the payments due to seller hereunder for the latest four  calendar years upon the request of seller and not more than once in any twelve  month period buyer shall permit and shall ensure that its affiliates permit an independent public accounting firm reasonably acceptable to buyer engaged by seller to examine such books and records insofar as they relate to such payments during normal business hours on reasonable prior written notice to audit buyer’s and its affiliates net sales as utilized to calculate the contingent asset purchase payments due seller hereunder provided  however  that such independent accountants shall not disclose buyer’s or its affiliates confidential information to seller except to the extent such disclosure is necessary to verify the amount of payments due hereunder if such accounting firm concludes that contingent asset purchase payments have been underpaid then unless buyer’s independent accounting firm disagrees with such conclusion buyer shall pay within thirty  days of the date that seller advises buyer in writing of such unpaid contingent asset purchase payments all such unpaid contingent asset purchase payments plus interest at a rate of the greater of a the us prime rate as reported in the wall street journal  eastern edition plus five percent  and b seven percent  per annum for the period between such unpaid contingent asset purchase payments should have been paid until such amounts are actually paid if such accounting firm concludes that contingent asset purchase payments have been overpaid then buyer shall be entitled to offset future contingent asset purchase payments by the amount so overpaid all expenses relating to such audit shall be borne by seller unless such audit discloses     certain information on this page has been omitted and filed separately with the securities and exchange commission confidential treatment has been requested with respect to the omitted portions     an underpayment in excess of five percent  with respect to a contingent asset purchase payment calculation in which case such expenses shall be paid by buyer d      notwithstanding anything to the contrary contained in this agreement i in no event shall buyer be obligated to make aggregate contingent asset purchase payments in excess of  and ii buyer shall have no further obligation to make contingent asset purchase payments upon buyer’s payment to seller of a onetime cash payment of  which buyer may make at any time from and after the initial closing date at buyer’s sole election for purposes of determining whether buyer has met the payment threshold set forth in clause i of this section d or the payment threshold set forth in clause ii of this section d  any amounts set off by buyer pursuant to its setoff rights and subject to the limitations thereon set forth herein shall be included in the calculation thereof e      it is agreed and clarified that a noninterbody product shall be deemed “subject to a valid claim”        seller acknowledgement setoff rights  a      seller expressly acknowledges and agrees that i upon the consummation of the transactions contemplated by this agreement buyer shall have the right to use the purchased assets and operate the medical device business and to use or not use the purchased assets in any way that buyer and its affiliates deems appropriate in buyer’s sole and absolute discretion ii the receipt of any milestone payments and contingent asset purchase payments is speculative and is subject to numerous factors outside the control of buyer and seller and there can be no assurance that seller will receive any of the milestone payments or contingent asset purchase payments and iii neither buyer nor any of its affiliates owes any implied duties to seller or its affiliates relating to section   section  or this section   b      buyer shall have the right to setoff or deduct from any of the milestone payments andor contingent asset purchase payments to satisfy i on a dollarfordollar basis the indemnification obligations of seller in accordance with and subject to the limitations set forth in article   and ii on a fordollar basis a the ocs transfer amount if buyer elects to make the buyer ocs payment election provided that buyer shall not be entitled to make such an election until after the failure of seller to pay the ocs transfer amount at least three  business days prior to the ocs transfer amount payment deadline such rights collectively the “ setoff rights ” and b without duplication any amount paid by buyer as part of the ocs transfer amount to ocs in excess of the aggregate sum of funding provided by the ocs to seller parent through the date hereof including funding provided through the ocs incubator program in which the seller parent participated plus interest accrued thereon if buyer elects to not terminate this agreement in accordance with section biii        transfer taxes  all sales use valueadded gross receipts excise registration stamp duty sales transfer or other similar taxes or governmental fees “ transfer taxes ” imposed levied or payable by reason of the signing of this agreement the transfer of assets and assumption of liabilities contemplated hereby or payment of any consideration hereunder shall be paid by party required to pay such taxes under applicable legal requirements     certain information on this page has been omitted and filed separately with the securities and exchange commission confidential treatment has been requested with respect to the omitted portions           allocation of purchase price  on or before the thirtieth th day of the month following the initial closing date and shares issuance date buyer shall deliver to seller an allocation of the initial closing cash consideration and the shares among the purchased assets the “ purchase price allocation ” the purchase price allocation shall be prepared by buyer in good faith and in accordance with applicable legal requirements should seller have any objections to the purchase price allocation buyer and seller shall work together in good faith for a period of thirty  days on a mutually acceptable purchase price allocation if buyer and seller cannot agree on such purchase price allocation in accordance with the provisions of this section    prior to the expiration of such thirty  day period the purchase price allocation shall be as determined by buyer in good faith and buyer and seller shall report such purchase price allocation in the filing of all tax returns or other document with or make any statement or declaration to any governmental body that is inconsistent with such purchase price allocation without the consent of the other party       withholding  notwithstanding anything to the contrary set forth herein buyer or buyer’s designee andor payment agent shall be entitled to deduct and withhold from any consideration payable to seller or any other person pursuant to this agreement such amounts as it is required to deduct and withhold under any provision of national federal state local or foreign tax law or other legal requirement or any applicable ruling or exemption from a governmental body provided  however  to the extent such seller or other person provides buyer with a valid certificate buyer will act in accordance with such valid certificate if the buyer so deducts or withholds any such amounts such amounts shall be treated for all purposes under this agreement as having been paid to the seller or such other person in respect of which buyer made such deduction and withholding in the event that buyer concludes that it is required to deduct or withhold from any consideration payable to seller or any other person pursuant to this agreement seller agrees to use commercially reasonable efforts to cooperate with buyer to enable buyer to make such withholding or deduction in accordance with any provision of national federal state local or foreign tax law or other legal requirement including without limitation by obtaining any applicable payment documentation from any governmental body “ valid certificate ” means a valid and applicable in light of the timing scope and the nature of the payment exemption or confirmation issued by the relevant governmental body with respect to the proposed withholding and with respect to seller or such other person which is sufficient to enable buyer to conclude at its reasonable discretion that no withholding or reduced withholding is required with respect to the contemplated payment to the seller or such other person article  closings         the initial closing  a      the initial closing of the transactions contemplated by this agreement shall be consummated the “ initial closing ” at the offices of amit pollak matalon  co at  raoul wallenberg street building d  th floor ramat hachayal tel aviv or to be held remotely via the electronic exchange of documents and signatures within three  business days following date on          which all of the conditions precedent to the initial closing set forth in section  and section  have been satisfied or waived or such other place time and date as the parties shall agree in writing the time and date on which the initial closing is actually held is referred to herein as the “ initial closing date ” all actions to occur at the initial closing shall occur and shall be deemed to take place simultaneously and no action shall be deemed to have been completed or any document delivered until all required actions have been completed and all required documents delivered b      from and after the initial closing and subject to compliance with applicable legal requirements seller shall only exercise any rights with respect to any medical device intellectual property the  remaining assets  in a manner that is consistent with the exclusive license agreement the transition services agreement after the shares issuance date and this agreement seller and buyer shall cooperate in good faith prior to the initial closing date to implement such arrangements as either party reasonably may request of the other party to ensure that to the greatest extent permitted by applicable legal requirements and subject to the terms of the exclusive license agreement the transition services agreement after the shares issuance date and this agreement from and after the initial closing the economic benefits and burdens of the initial closing purchased assets transferred at the initial closing are held and borne by buyer c      subject to fulfillment or waiver of the conditions set forth in section   at the initial closing buyer shall deliver or cause to be delivered to seller each of the following i      the initial closing cash consideration ii      the certificate contemplated by section a  duly executed by an authorized officer of buyer iii      certified copies of the resolutions duly adopted by the board of directors of buyer authorizing the execution delivery and performance of this agreement and the additional agreements and the consummation of the transactions contemplated hereby and thereby and iv      the initial closing additional agreements duly executed by buyer   d      subject to fulfillment or waiver of the conditions set forth in section   at the initial closing seller shall deliver or cause to be delivered to buyer each of the following i      a copy of the ocs preliminary conditional approval ii      certificates of title or origin or like documents or any certificate or document required by any governmental body with respect to any asset included in the initial closing purchased assets which is required in order to transfer title   iii      all notices consents waivers releases and approvals listed on schedule diii hereto including evidence satisfactory to buyer of the making of any notice filings required to be made with the fda or other governmental body or person          iv      the certificate contemplated by section a  duly executed by an authorized officer of each of seller subsidiary and seller parent v      certified copies of the resolutions duly adopted by the boards of directors of each of seller subsidiary and seller parent authorizing the execution delivery and performance of this agreement and the additional agreements and the consummation of the transactions contemplated hereby and thereby vi      good standing certificate for seller subsidiary from the secretary of state of the state of delaware dated not more than five  days prior to the initial closing date vii      evidence of the discharge removal and termination of all encumbrances to which such initial closing purchased assets are subject other than permitted encumbrances which releases shall be effective at or prior to the initial closing viii      all records relating to the medical device business which are reasonably required by buyer in order to exercise its rights under the exclusive license agreement ix      all documents and other materials reasonably required by buyer in order to exercise its rights under the exclusive license agreement x      the initial closing additional agreements duly executed by seller xi      an undertaking in form and substance satisfactory to buyer from each of seller’s lenders that they will not require repayment of their loans until seller parent and seller subsidiary shall have delivered or caused to be delivered all deliverables under section c of this agreement including without limitation evidence satisfactory to buyer of seller parent’s payment of the ocs transfer amount to the ocs and xii      such other bills of sale assignments and other instruments of transfer or conveyance as buyer may reasonably request or as may be otherwise necessary to evidence and effect the sale assignment transfer conveyance and delivery of the initial closing purchased assets to buyer       the subsequent closing  a      an additional subsequent closing of the transactions contemplated by this agreement shall be consummated the “ subsequent closing ” and the initial closing and the subsequent closing are each sometimes individually referred to herein as a “ closing ” and collectively as the “ closings ” at the offices of amit pollak matalon  co at  raoul wallenberg street building d  th floor ramat hachayal tel aviv or to be held remotely via the electronic exchange of documents and signatures within three  business days following date on which all of the conditions precedent to the subsequent closing set forth in section  and section  have been satisfied or waived or such other place time and date as the parties shall agree in writing          provided however that unless otherwise agreed by the parties the subsequent closing shall not take place prior the ocs transfer amount payment deadline the time and date on which the subsequent closing is actually held is referred to herein as the “ subsequent closing date ” and the initial closing date and the subsequent closing date are each sometimes individually referred to herein as a “ closing date ” and collectively as the “ closing dates ” all actions to occur at the subsequent closing shall occur and shall be deemed to take place simultaneously and no action shall be deemed to have been completed or any document delivered until all required actions have been completed and all required documents delivered b      subject to fulfillment or waiver of the conditions set forth in section   at the subsequent closing buyer shall deliver or cause to be delivered to seller each of the following i      the certificate contemplated by section a  duly executed by an authorized officer of buyer and ii      the subsequent closing additional agreements duly executed by buyer c      subject to fulfillment or waiver of the conditions set forth in section   at the subsequent closing seller shall deliver or cause to be delivered to buyer each of the following i      evidence satisfactory to buyer of seller’s payment of the ocs transfer amount to the ocs ii      certificates of title or origin or like documents or any certificate or document required by any governmental body with respect to any asset included in the purchased assets which is required in order to transfer title   iii      all notices consents waivers releases and approvals listed on schedule ciii hereto including evidence satisfactory to buyer of the making of any notice filings required to be made with the fda or other governmental body or person iv      the certificate contemplated by section a  duly executed by an authorized officer of each of seller subsidiary unless seller subsidiary has been dissolved and seller parent v      good standing certificate for seller subsidiary from the secretary of state of the state of delaware unless seller subsidiary has been dissolved dated not more than five  days prior to the subsequent closing date vi      evidence of the discharge removal and termination of all encumbrances to which the remaining assets are subject other than permitted encumbrances which releases shall be effective at or prior to the subsequent closing vii      all records relating to the medical device business which were not delivered at the initial closing          viii      the subsequent closing additional agreements duly executed by seller and ix      such other bills of sale assignments and other instruments of transfer or conveyance as buyer may reasonably request or as may be otherwise necessary to evidence and effect the sale assignment transfer conveyance and delivery of the remaining assets to buyer  article  representations and warranties of seller   as an inducement to buyer to enter into this agreement and to consummate the transactions contemplated hereby subject to the schedules prepared by seller relating to this article  the “ schedules ” seller parent and seller subsidiary hereby jointly and severally represent and warrant to buyer as of the date hereof and as of the initial closing date and the shares issuance date as follows       organization  a      seller parent is an israeli company with limited liability duly formed validly existing and to the extent such concept is applicable under the laws of the state of israel in good standing under the laws of the state of israel seller parent is duly qualified to carry on the medical device business as now conducted and is in good standing in each of the jurisdictions in which the ownership or leasing of the purchased assets or the conduct of the medical device business requires such qualification except where such failure to be so qualified or in good standing would not reasonably be expected to result in a material adverse effect seller parent has full corporate power and authority to own or lease and to operate and use the purchased assets and to carry on the medical device business as now conducted the articles of association of the seller parent as in effect as of the date hereof are attached as schedule a the “ current articles ” b      seller subsidiary is a corporation duly formed validly existing and in good standing under the laws of the state of delaware seller subsidiary is duly qualified to carry on its business as now conducted and is in good standing in each of the jurisdictions in which the ownership or leasing of its assets or the conduct of its business requires such qualification except where such failure to be so qualified or in good standing would not result in a material adverse effect seller subsidiary has full corporate power and authority to own or lease and to operate and use its assets and to carry on its business as now conducted other than seller subsidiary seller parent does not directly or indirectly own beneficially or of record any outstanding equity of or financial interest in any entity seller parent is the sole stockholder of seller subsidiary       authorization  a      seller has full corporate power and authority to execute deliver and perform this agreement and each of the additional agreements to which it is a party and to consummate the transactions contemplated hereby and thereby the execution delivery and performance of this          agreement and the additional agreements by seller have been duly and validly authorized and approved by seller by all necessary corporate action each of the boards of directors of seller subsidiary and seller parent has unanimously i duly approved this agreement and the transactions contemplated hereby and ii  determined that in its opinion the transactions contemplated hereby are expedient and for the best interests of seller subsidiary or seller parent as applicable other than the consent of um accelmed limited partnership no other vote or consent of the holders of any of the seller parent’s or seller subsidiary’s share capital are necessary under the laws of the jurisdiction of organization or the organizational documents of seller parent and seller subsidiary for them to approve and adopt this agreement and the transactions contemplated hereby b      this agreement has been and the additional agreements upon execution and delivery by seller will be duly authorized executed and delivered by seller and constitutes or upon execution and delivery will constitute as the case may be legal valid and binding obligations of seller enforceable against seller in accordance with their terms except i as such enforcement may be subject to bankruptcy insolvency reorganization moratorium or other similar laws now or hereafter in effect relating to creditors’ rights and ii as the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought c      except as set forth on schedule c  neither the execution delivery and performance of this agreement or any of the additional agreements nor the consummation of any of the transactions contemplated hereby or thereby nor compliance with or fulfillment of the terms conditions and provisions hereof or thereof will i violate conflict with or result in the breach of any provision of the current articles charter bylaws or any other organizational documents of seller ii violate or conflict with any legal requirements or governmental order applicable to seller iii result in the creation or imposition of any encumbrance upon any of the purchased assets or iv require the approval consent authorization or act of or the making by seller of any declaration filing or registration with any governmental body or other person other than as expressly contemplated in this agreement d      the purchased assets including the medical device intellectual property are to the extent owned by seller solely and exclusively owned by seller parent and not seller subsidiary and therefore seller subsidiary has no rights to receive any of the initial closing cash consideration the shares the milestone payments if any and contingent asset purchase payments if any       taxes  a      all tax returns that were or will be required to be filed by or with respect to seller on or before either the initial closing date or the subsequent closing date have been or will be filed on a timely basis in accordance with the laws regulations and administrative requirements of the appropriate governmental body in all jurisdictions in which such tax returns were or will be required to be filed all such tax returns that have been filed were when filed and continue to be true correct and complete          b      all taxes due and payable on or before the either the initial closing date or the subsequent closing date that are either i  required to be shown on any tax return filed by or with respect to seller or ii  which were not required to be shown on any tax return but which were or will be required to be paid by or with respect to seller have been or will be timely paid on or before either the initial closing date or the subsequent closing date all taxes that seller was or will be required by law to withhold or collect have been in the case of those that were already required to be withheld or collected or will be duly withheld or collected and to the extent required have been in the case of those that were already required to be paid or will be paid to the appropriate governmental body there are no encumbrances and will be no encumbrances on either the initial closing date or the subsequent closing date with respect to taxes upon any of the purchased assets any liability of seller for taxes not yet due and payable has adequately been provided for by seller on the financial statements whether or not required to be disclosed under gaap c      there is no action dispute suit proceeding investigation assessment audit or claim now pending against or with respect to seller in respect of any tax nor is any action dispute suit proceeding investigation assessment audit or claim for additional tax expected by seller to be asserted by any governmental body d      neither seller parent nor seller subsidiary is subject to any restrictions or limitations pursuant to part e of the israeli tax ordinance new version the “ ito ” or pursuant to any tax ruling made with reference to the provisions of part e of the ito       sufficiency of assets  except as set forth on schedule  the purchased assets are suitable for the uses to which they are being put or have been put in the ordinary course of business of the medical device business and the purchased assets constitute all of the material assets necessary to conduct the medical device business as currently conducted       compliance with laws  a      the medical device business as conducted to date and the purchased assets and their current uses comply in all material respects with all applicable legal requirements and governmental orders b seller has complied in all material respects with all legal requirements and governmental orders which are applicable to the use and operation to date of purchased assets or the medical device business as conducted to date and c to the knowledge of seller no governmental body has at any time challenged or questioned the legal right of seller to sell any of its products or to provide any of its services in the manner provided to date b      neither seller nor any of its directors executives representatives agents or employees on behalf of seller i has used or is using any funds for any illegal contributions gifts entertainment or other unlawful expenses relating to political activity ii has used or is using any funds for any direct or indirect unlawful payments to any foreign or domestic government officials or employees iii has violated or is violating any provision of the us foreign corrupt practices act of  “ fcpa ” sections  of the israeli penal law  bribery transactions the israeli prohibition on money laundering law  or any other applicable anticorruption or antibribery related legal requirements iv has established or maintained or is maintaining any unlawful fund of corporate monies or other properties or v has directly or indirectly made          offered promised or authorized any bribe unlawful rebate unlawful payoff influence payment kickback or other unlawful payment of any nature c      seller is and has been in compliance in all material respects with applicable international trade law including all laws and regulations related to the imports and exports from and into the united states and israel and the payment of required duties and tariffs in connection with same seller has not received any written notice from any governmental body of any actual or potential violation or failure to comply with any international trade law       governmental permits  a      seller is in possession of those franchises authorizations licenses permits consents certificates clearances approvals and registrations of any governmental body necessary for seller to own lease and operate its properties and assets or to carry on the medical device business in each case as sellers activities to date require the “ governmental permits ” a list of those governmental permits which are possessed by seller is set forth in schedule a  complete and correct copies of all of the transferred permits have heretofore been delivered or will be delivered prior to the initial closing date to buyer by seller b      i seller has fulfilled and performed its obligations under each of the governmental permits and no event has occurred or condition or state of facts exists which constitutes or after notice or lapse of time or both would constitute a breach or default or violation under any such governmental permit or which permits or after notice or lapse of time or both would permit revocation or termination of any such governmental permit or which might adversely affect in any material respect the rights of seller under any such governmental permit ii no notice of cancellation of default of violation or of any material dispute concerning any governmental permit or of any event condition or state of facts described in the preceding clause has been received by or is known to seller and iii each of the transferred permits is valid subsisting and in full force and effect and may subject to applicable legal requirements be assigned and transferred to buyer in accordance with this agreement and will continue in full force and effect thereafter in each case without a the occurrence of any breach default or forfeiture of rights thereunder or b the consent approval or act of or the making of any filing with any governmental body       title to purchased assets  other than as set forth in schedule   seller has good marketable and insurable title to all of the purchased assets free and clear of all encumbrances other than permitted encumbrances the purchased assets are not subject to any liability or obligation of whatever nature whether known or unknown absolute accrued contingent or otherwise other than obligations to the ocs upon delivery to buyer on the applicable closing date of the instruments of transfer contemplated by section   and section  seller will thereby transfer to buyer good marketable and insurable title to the applicable purchased assets free and clear of encumbrances other than permitted encumbrances       intellectual property  a      schedule a sets forth the following          i      a complete list of all patents and any applications therefor in respect of any of the foregoing included in the medical device intellectual property which specifies where applicable the jurisdictions in which such medical device intellectual property right has been issued or registered or in which an application for such issuance and registration has been filed including the respective registration or application numbers and the names of all registered owners all registered patents included in the medical device intellectual property and held by seller if any are valid and subsisting ii      all licenses sublicenses and other agreements as to which seller is a party and pursuant to which seller is authorized to use any medical device intellectual property belonging to any third party  provided  however  that seller need not list object code end‑user licenses granted to endusers in the ordinary course of business that permit use of software products without a right to modify distribute or sublicense the same including the identity of all parties thereto a description of the nature and subject matter thereof the applicable royalty and the term thereof and iii      all licenses sublicenses and other agreements as to which seller is a party and pursuant to which seller has granted to any third party any right to use any of the medical device intellectual property including the identity of all parties thereto a description of the nature and subject matter thereof the applicable royalty and the term thereof iv      seller has provided buyer with access to complete and accurate copies of all applications registrations agreements and other documents referenced in schedule a to which buyer has requested access seller has no registered or pending applications for registration in respect of any trademarks or copyrights that are medical device intellectual property b      seller is not in violation in any material respect of any license sublicense or agreement described or to be described on schedule a and the execution and delivery of this agreement by seller and the consummation of the transactions contemplated hereby i will not cause seller to be in violation or default under any such license sublicense or agreement ii will not entitle any party to any such license sublicense or agreement to terminate or modify such license sublicense or agreement or iii will not require seller to repay any funds already received by it from any person c      except as set forth on schedule c  seller owns or has valid rights in and to free and clear of any encumbrances other than permitted encumbrances all the medical device intellectual property is not contractually obligated to pay any compensation to any person in respect thereof for the use thereof or the material covered thereby in connection with the services or products in respect of which the medical device intellectual property is being used no claims with respect to the ownership of or otherwise questioning seller’s rights to any of the medical device intellectual property have been asserted or are threatened by any person nor to the knowledge of seller are there any valid grounds for any such claim          d      none of the medical device intellectual property the manufacturing use andor sale of the medical device products nor the conduct of the medical device business has infringed misappropriated or conflicted with any patents trademarks copyrights trade secrets or other intellectual property of any person seller has not received any claims nor to the knowledge of seller are any claims threatened or do valid grounds exist for any claims to the effect that the manufacture sale licensing or use of any of the medical device products as now manufactured sold licensed or used by or on behalf of seller infringes the intellectual property rights of any person e      to the knowledge of seller there is no unauthorized use infringement or misappropriation of any of the medical device intellectual property by any employee or former employee of seller f      none of the medical device intellectual property or the medical device products is subject to any outstanding decree order judgment or stipulation relating specifically to them and restricting in any manner the licensing thereof by seller g      seller has taken reasonable measures to protect and maintain the secrecy and confidentiality of all material trade secrets of seller and to the knowledge of seller such trade secrets have not been disclosed by seller to any person except pursuant to written nondisclosure agreements h      all persons including past and present employees contractors and consultants of seller i who were involved in the development creation or conception of any medical device intellectual property have entered into written agreements with seller pursuant to which such persons employees contractors and consultants validly and irrevocably assigned to seller all intellectual property so developed created and conceived validly waived any moral rights with respect to such intellectual property and validly waived any right to any royalty compensation or other remuneration provided by local custom administrative regulation governmental statute or otherwise including under the israeli patents law  the “ israeli patents law ” and ii who have had access to trade secrets of seller are bound by written agreements or otherwise have obligations pursuant to which such persons are bound to protect such confidential information and trade secrets of seller and to the knowledge of seller no such person has breached its obligations to seller the seller does not owe any compensation or remuneration to any employee consultant contractor or other person in respect of any medical device intellectual property including with respect to any patent that is based on an invention of or copyright that is based on a work of any person including past and present employees contractors and consultants of seller and each such person has received full and fair compensation with respect to any such medical device intellectual property including according to the israeli patents law i      seller is not now nor has seller ever been a member or a contributor to or made any commitments or agreements regarding any patent pool industry standards body standard setting organization industry or other trade association or similar organization in each case that could or does require or obligate seller to grant or offer to any other person any license or other right to any intellectual property owned by seller          j      except as set forth in schedule j  seller has no obligation to pay any royalties license fees or other amounts or provide or pay any other consideration to any person for the use exploitation practice development licensing sale or disposition of any medical device intellectual property or any tangible embodiment thereof or medical device product there are no pending or to the knowledge of seller threatened claims against the seller from any person in any jurisdiction for compensation remuneration or royalties for inventions invented copyright works created or any similar claim including under the israeli patents law k      except as set forth in schedule k  no funding facilities resources or personnel of any governmental body or any university college other educational institution multinational binational or international organization or research center or other governmental grant was used or received in connection with the development or creation in whole or in part of any medical device intellectual property or medical device product l      none of the execution delivery or performance of this agreement or any ancillary agreement contemplated hereby nor the consummation of the transactions contemplated by this agreement or such ancillary agreements or the satisfaction of any closing condition set forth herein will contravene conflict with or result in any termination of or new or additional limitations on the buyer’s right title or interest in or to the medical device intellectual property nor will it cause i seller to grant to any other person any right to or with respect to any medical device intellectual property ii seller to be bound by or subject to any noncompete or other restriction on the operation or scope of their respective businesses or iii seller to be obligated to pay any royalties or other fees or consideration to any person m      subject to payment of the ocs transfer amount and except as set forth in schedule m  all seller owned medical device intellectual property is fully transferable alienable and licensable by seller without restriction and without obligation to make further payment of any kind to any other person       no accounts receivable no inventory books of account  a      there are no accounts receivable of seller related to the medical device business b      there are no unfilled purchase and sales orders of seller related to the medical device business c      seller has no inventory including raw materials works in progress and finished goods inventory of products supplies and parts of the medical device business d      the books records and accounts of seller maintained with respect to the medical device business reflect all transactions and all assets and liabilities of seller with respect to the medical device business                contracts  intentionally omitted       no litigation  except as set forth on schedule   as of the date hereof there is no suit claim action investigation or proceeding pending or to the knowledge of seller threatened against seller or any of their respective properties or assets or to the knowledge of seller any officer or director of seller in their capacities as such nor to seller’s knowledge is there any basis for any such claims and there are no lawsuits suits or proceedings pending in which seller is the plaintiff or claimant in all cases related to the medical devices business or the purchased assets as of the date hereof neither seller nor any of its properties or assets is subject to any outstanding governmental order or settlement obligation in any case under which seller has any ongoing obligations there is no action suit or proceeding pending or to the knowledge of the seller threatened which questions the legality of the transactions contemplated by this agreement       environmental matters  seller has complied with and is in compliance in all material respects with all applicable environmental and safety requirements seller has not received any oral or written notice report or information regarding any actual or alleged violati bbb business profile  legalzoomcom home    accredited business directory    legal forms    legalzoomcom bbb accredited business profile is this your business claim it now legalzoomcom request a quote legalzoomcom business information   legalzoomcom  years in business  n brand blvd th fl glendale ca  website additional phone numbers     see less contact options see more contact options find a location business started  business incorporated  in de type of entity corporation business management chyna smith business category legal forms legal services plans divorce assistance see more business categories see less business categories alternate business names legalzoomcom inc licensing bonding or registration this business is in an industry that may require professional licensing bonding or registration bbb encourages you to check with the appropriate agency to be certain any requirements are currently being met number of employees   see less business information see more business information business information a bbb rating scorecard request a quote share your experience submit a review submit a complaint bbb reason for ratings bbb rating is based on  factors get the details about the factors considered bbb reports on licensing licensing information is provided in the bbb business profiles to inform the public about industries that may require professional licensing bonding or registration better business bureau encourages you to check with the appropriate agency to be certain any requirements are currently being met advertising review bbb promotes truth in advertising by contacting advertisers whose claims conflict with the bbb code of advertising these claims come to our attention from our internal review of advertising consumer complaints and competitor challenges bbb asks advertisers to substantiate their claims change ads to make offers more clear to consumers and remove misleading or deceptive statements government actions bbb reports on known significant government actions involving the businesss marketplace conduct out of business bbb reports on a company that is out of business for three years from the date the company closes its doors or ceases to do business misuse of better business bureau namelogo bbb reports on unauthorized use of the better business bureaus name andor logo for as long as the business continues to use it in any advertising or for one year after the business ceases any repeated unauthorized uses bankruptcy bbb reports on a business’s bankruptcy as long as the business remains in bankruptcy mail returned bbb reports when mail sent to the business was returned by the postal service legalzoomcom bbb rating scorecard legalzoomcom bbb accreditation since  a bbb rating system overview customer review rating the bbb customer review rating represents the customers opinion of the business the customer review rating percentages are based on the total number of positive neutral and negative reviews posted   positive reviews  neutral reviews  negative reviews  total customer reviews  total customer complaints composite score legalzoomcom has received  out of  stars based on  customer reviews and a bbb rating of a comprised of  bbb rating and  customer review rating the bbb customer review rating represents the customers opinion of the business the customer review rating percentages are based on the total number of positive neutral and negative reviews posted the bbb letter grade represents the bbbs opinion of how the business is likely to interact with its customers the bbb grade is based on bbb file information about the business in some cases a business grade may be lowered if the bbb does not have sufficient information about the business despite bbbs requests for that information from the business the bbb customer review rating plus the bbb rating is not a guarantee of a business reliability or performance bbb recommends that consumers consider a business bbb rating and customer review rating in addition to all other available information about the business request a quote share your experience submit a review submit a complaint share print × claim your business by claiming your business profile businesses can add custom text or descriptive information about their services insert company logos and add photographs for consumers to view close × accreditedquestionmodal title content close × customer rating modal title content close × score modal title content close × find a location filter close um accelmed limited partnership top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active um accelmed limited partnership • sacramento ca how do i update this listing um accelmed limited partnership is based out of sacramento whalewisdom has at least  dg filings in our database for um accelmed limited partnership summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from um accelmed limited partnership enter your email address below and choose submit your email cancel contact info um accelmed limited partnership co ophthalmic imaging systems sacramento ca     business phone   recent sec filings sc da filed on  sc d filed on  sc da filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free search engine marketing sem  bing ads skip to content sign upsign in   you run your business well help find your customers bing ads can help build your business and drive your success spend  and get  in advertising credit† †offer details get  in search advertising when you spend  in bing ads coupon code class first name last name email your website url business phone required microsoft may contact you to provide updates and special offers about bing ads you can unsubscribe at any time to learn more you can read the privacy statement type the code from the image enter security code   × get  in search advertising when you spend  in bing ads †offer details offer expires december   valid only for new bing ads customers who are first party recipients of the offer email a new bing ads customer is one that has not advertised on bing ads before enter promotional coupon code and spend  applies to threshold and prepaid accounts to receive  in bing ads credits limit one promotion code per new bing ads customer promotional code must be redeemed within thirty  days of bing ads new customer account creation ad campaign costs accrued before receiving a credit as well as costs accrued after all credits are used will be charged to the payment method associated with the bing ads account if customer payment fails the coupon amount will not be applied ads will continue to run and accrue costs after any promotional credit has been used up any portion of the credit not used within ninety  days of credit redemption will expire and cant be carried over even if the bing ads customer switches their payment method offer valid only to residents of the united states in order for the offer to be valid a form of payment must be entered into your account prior to redemption of the promotional code and prior to your account going live to take advantage of the credit this offer may not be combined with any other offer promotional code coupon or discount separated redeemed for cash transferred sold or bartered microsoft in its sole discretion can close your account for any suspected coupon abuse refund of the  is not permitted see bing ads terms and conditions for more details at signup other terms and conditions may apply microsoft reserves the right to cancel change or suspend this offer at any time without notice see how bing ads works customers search customers see your ad customers contact you watch how bing ads works     × how bing ads works help more customers find you see how bing can attract customers your google adwords campaigns cant reach  million searchers on the bing network tap into  of the search marketplace get in front of searchers who spend  percent more than the average internet searcher powerful network powerful benefits reach across devicesconnect with customers looking for your business anytime anywhere on any device go global or localreach people in the bing network everywhere or focus on cities counties and areas within a certain distance from your business easy to importif youre already using another product like google adwords its easy to pull that campaign into bing ads you control your costs  free signupjoin bing ads for free and control your account at every step  only pay for clickspay just when customers click on your ad no click no charge  no minimum feestart advertising with a budget that works best for your business   the advantage we gain in cost per click gives us a great return on investment — more than  percent better than google adwords scott redgate search engine marketing manager — cj pony parts by using bing ads features like image extensions and sitelink extensions this auto parts retailer races to convert customers and beat its competition  read about driving more conversions   we might not get as much of the volume as with google adwords but the volume of the traffic that we get converts really well at a lower cost scott schult executive vice president of marketing — myrtle beach area convention and visitors bureau the myrtle beach area convention and visitors bureau uses bing ads to drive site traffic and tourism at lower cost  read about getting better roi better results for less cost thats as simple as i can make it if i look at the quality of the traffic we get for the dollars we spend on bing ads our roi is fantastic alex littlewood ceo   motoroso motoroso a market network for auto enthusiasts gets better results for less cost and reaches a highvalue audience with bing ads  read about attracting quality traffic   import your adwords campaigns save time by importing your google adwords campaigns into bing ads to get ads live quickly sign in with your microsoft account or create one to get started on bing ads from within the bing ads interface select the import from google adwords option enter your google adwords credentials and select the campaign you want to import preview your ad get found online with search engine marketing make the most of your marketing dollars and drive customers to your business see how bing ads can work for you get started today give us a few details about your business to create a bing ads account and get it up and running   sign up get started with bing ads signing up is always free faq is bing ads right for me is bing ads right for my business all types of businesses find value and success with bing ads whether youre focused on local calls and foot traffic or want to drive traffic to your website from across the country or around the world bing ads has solutions for you i already appear in search results for free why should i pay for advertising your current customers may search for your business by name aiming it easy to find you in search results but customers youve yet to reach are more likely searching for general terms that wouldnt necessarily bring up your business in search results advertising next to relevant bing search results puts your business front and center with interested customers you otherwise might not reach what is the difference between seo and sem which one is right for me search engine optimization seo is adjusting your website to improve your natural ranking in search results you cannot pay to improve your website ranking on bing or yahoo thus we often refer to these results and unpaid or organic search results clicks from seo are free but seo also requires technical expertise and involves some factors over which you have only limited control search engine marketing sem is paid advertising that appears next to or above unpaid or organic search results these paid ads are purchased through bing ads you pay for sem clicks but sem gives you more control over when your website appears on results pages and you decide how much you want to pay and you can measure which ads are working and quickly improve your results you dont have to choose between seo and sem you can do both if my time is limited should i still try bing ads yes call a bing ads specialist at and we’ll set up your first campaign for you for free we’ll give you tips on getting the most out of your ads and set you up for success we’re here to help about bing ads where does my ad appear your ads could appear on the top or to the right of bing yahoo and msn search results and you can choose to target your ads to different geographic regions times or days of the week and even demographics what determines my ad position bing ads is a payperclick ppc advertising system you bid based on how much you are willing to pay per each click on your ad because webpages have a limited number of places to show ads we auction those spaces you are bidding against other advertisers to get your ads into the space you want so if you bid on the keyword shoe you will have to beat the bids of the other advertisers who are also bidding on shoe you determine how much you are willing to bid your ad position is based on several things including how closely your ad and website fit with the terms that are searched relevance how your bid compares to other bids in the bing ads auction how strongly your ad has performed in the past and how often it has been clicked clickthrough rate the stronger you are in these areas the better your chances of winning the top ad position how to use bing ads how can i use bing ads to drive more people to my website here are some tips to get better results review your budget and bid strategy if your ad keeps pausing your budget limit may be set too low competitive bids help your ad stay in a strong position to catch eyes and get more clicks to your website expand your targeting both for location and for devices computer mobile and tablet make sure your ads and website are relevant to the keywords you bid on would someone searching your terms expect to see and ad for your business how can i keep my costs down while your first instinct may be to lower your budget first try lowering your maximum bids yes this could mean fewer customers visit your site but if you increase your quality score and build ads with a strong performance history you may be able to win a good ad position with a lower bid that would lower your costperclick and help stretch your budget how do i know if bing ads is working view a wide range of performance trends in your account to quickly see key stats ad clicks the number of times your ad appeared impressions spend average costperclick clickthrough rate average ad position cost per acquisition and conversions you can also run performance reports to get insights into how well your campaigns are doing can i run more than one ad yes in fact we encourage it only one ad will show at a time but running multiple ads lets you test different approaches to see whats working best with your target customers frequently businesses try out different ads for specific products or pages getting started with bing ads how do i get started sign up for bing ads which keywords should i choose you have a few options to help choose your keywords first youll want to think of the terms one of your customers might use to search for your products and offerings those search terms are a great starting point then you can use tools right in your account to find more keywords within bing ads click campaigns on the top of the page click the keywords tab and then click add keywords this will let you search for new keywords based on one you enter search a website for keywords search your destination urls for keywords how can i write a good ad here are a few tips that can help make your ad stand out keep your ads relevant one way to improve relevance is to use your customers most popular search terms in your ad titles and txt describe what sets your product apart use your customers language use words and writing tone that are likely to attract your typical customer be specific this clearer and more specific your offering the better for example rather than big discount specify and exact percentage such as  percent off give customers a reason to click your ad right now offer a specific call to action such as encouraging customers to request a brochure or consultation download a free ebook subscribe to a newsletter or take advantage of a limitedtime discount sign up with bing ads to get started purchase and sale agreement purchase and sale contracts  free legal documents page  of   you are here agreements  purchase and sale agreement search documents  browse documents site search agreements  contracts document title entire documentoptional governing lawoptional allalabamaalaskaarizonaarkansascaliforniacoloradoconnecticutdelawareflorida georgiahawaiiidahoillinoisindianaiowakansaskentuckylouisianamainemaryland massachusettsmichiganminnesotamississippimissourimontananebraskanevada new hampshirenew jerseynew mexiconew yorknorth carolinanorth dakotaohiooklahoma oregonpennsylvaniarhode islandsouth carolinasouth dakotatennesseetexasutah vermontvirginiawashingtonwest virginiawisconsinwyoming try our advanced search  clauses search contract clauses  browse contract clause library a purchase and sale agreement is a document used in real estate transactions when a seller property owner seller sells a property to a company or individual buyer this document outlines the terms and conditions of transaction information contained in the document includes the names of both parties the address and description of the property the agreement concerns and the purchase price the closing details of the transaction are included in the document outlining where and when closing on the property shall occur when purchasing a property particularly with a cash payment a real estate investor may provide earnest money as a deposit this information will be present in the contract and will include details on the amount and how it shall be paid to the seller if a loan is being used to purchase the property details of the lender and the amount will be included in the documentthere may be clauses regarding property taxes and disclosures of potential issues of the property if the seller agrees to perform certain repairs before transfer of ownership to the buyer the repairs may be contained within the agreement some buyers may request fixtures or furnishings along with the sale of the property and these will be listed within the document a purchase and sale agreement may also contain warranties waiver of claims and information about the title insurance policy purchase and sale agreements these purchase and sale agreements are actual legal documents drafted by top law firms for their clients use them for competitive intelligence drafting documents or to get information about transactions within a particular industry or sector we have millions of legal documents and clauses that you can search for free  warrant to purchase stockparties numerex corp pa  kenneth rainin foundation  numerex corp law firm kaye scholerarnold porter document date  governing lawnew york  mortgage loan purchase agreementparties jpmdb commercial mortgage securities trust c  cwcapital asset management llc  park bridge lender services llc  purchaser jp morgan chase commercial mortgage securities corp  seller jpmorgan chase bank national association  wells fargo bank national association  wilmington trust national association law firm sidley austincadwalader wickersham document date   series a preferred unit purchase agreementparties energy transfer equity lp  energy transfer equity lp  le gp llc  sunoco gp llc  sunoco lp law firm latham watkinsandrews kurth document date  governing lawdelaware  for immediate releaseparties boston scientific corp  boston scientific corporation  strengthen company  symetis sa document date   mortgage loan purchase agreementparties wells fargo commercial mortgage trust rb  academy securities inc  barclays capital inc  ciii asset management llc  depositor and wells fargo bank national association  purchaser wells fargo bank  ross stewart wells fargo bank national association  sg americas securities llc  trimont real estate advisors llc  ubs securities llc  wells fargo commercial mortgage securities inc  wells fargo securities llc  wilmington trust national association law firm carlton fields document date  governing lawnew york  vmware announces  million stock purchase agreement with dellparties vmware inc  dell technologies inc  vmware inc document date   unaudited pro forma condensed consolidated financial informationparties systemax inc  hilco capital limited  misco solutions bv  systemax business services kft misco uk limited systemax italy srl misco iberia computer supplies sl misco ab global directmail bv document date   mortgage loan purchase agreementparties wells fargo commercial mortgage trust rb  academy securities inc  barclays capital inc  ciii asset management llc  depositor and wells fargo bank national association  purchaser wells fargo bank  trimont real estate advisors llc  ubs ag  ubs securities llc  wells fargo commercial mortgage securities inc  wells fargo securities llc  wilmington trust national association law firm carlton fields document date  governing lawnew york  subscription agreementparties precise acquisition inc  wilmington trust national association fbo precise acquisition inc document date   mortgage loan purchase agreementparties wells fargo commercial mortgage trust rb  academy securities inc  barclays capital inc  ciii asset management llc  depositor and wells fargo bank national association  purchaser wells fargo bank  sg americas securities llc  trimont real estate advisors llc  ubs securities llc  wells fargo commercial mortgage securities inc  wells fargo securities llc  wilmington trust national association law firm carlton fields document date  governing lawnew york  warrant agreementparties silver run acquisition corp ii  continental stock transfer trust company  riverstone vi sr ii holdings lp  silver run acquisition corporation  silver run sponsor ii llc document date  governing lawnew york  securities purchase agreementparties generex biotechnology corp  generex biotechnology corporation law firm eckert seamans document date  governing lawnew york  mortgage loan purchase agreementparties jpmcc commercial mortgage securities trust jp  jp morgan chase commercial mortgage securities corp  lnr partners llc  midland loan services  pentalpha surveillance llc  pnc bank national association  starwood mortgage capital llc  starwood mortgage funding vi llc  wells fargo bank national association law firm sidley austincadwalader wickersham document date  governing lawdelaware  american assets trust inc enters into purchase agreement to acquire the pacific ridge apartments in san diego california company release  parties american assets trust lp  san diego american assets trust inc document date   stock purchase agreement dated as of march   amongparties seaworld entertainment inc  blackstone group  citibank na  seaworld entertainment inc  sun wise uk co ltd  sw cayman limited  zhonghong zhuoye group co ltd law firm paul hastingssimpson thacher document date  governing lawdelaware  guardion health sciences inc preferred stock purchase agreement series bparties guardion health sciences inc  guardion health sciences inc document date  governing lawcalifornia  warrant to purchase common stockparties novabay pharmaceuticals inc  novabay pharmaceuticals inc document date  governing lawnew york  warrant to purchase common stockparties novabay pharmaceuticals inc  novabay pharmaceuticals inc document date  governing lawnew york  warrant to purchase common stockparties novabay pharmaceuticals inc  warrant should contact novabay pharmaceuticals inc document date  governing lawcalifornia  trust sale agreement between ally auto assets llc depositor and ally auto receivables trust  issuing entity dated as of march  parties ally auto assets llc  closing date ally bank  deutsche bank national trust company  deutsche bank trust company document date  governing lawnew york  cnh equipment trust a purchase agreementparties cnh capital receivables llc  cnh industrial capital america llc law firm greenberg traurig document date  governing lawnew york  quest management inc announces sale of control block and addition of new business initiativesparties quest management inc  madona latvia quest management inc  quest managements president mr dmitrij ozolins and tn llc document date   cerulean pharma and daré bioscience enter into stock purchase agreement transaction to create nasdaqlisted company focused on the development and commercialization of womens reproductive health products sabrina martucci johnson to be named ceo of combined company cerulean and daré to host joint coparties cerulean pharma inc  cerulean pharma inc  combined company  daré bioscience inc law firm wilmer cutlermintz levin document date   cnh equipment trust a purchase agreementparties cnh capital receivables llc  cnh industrial capital america llc law firm greenberg traurig document date  governing lawnew york  cnh equipment trust a purchase agreementparties cnh equipment trust a  cnh capital receivables llc  cnh industrial capital america llc law firm greenberg traurig document date  governing lawnew york  warrant to purchase shares of common stockparties viewray inc  viewray inc law firm latham watkins document date  governing lawcalifornia  warrant to purchase shares of common stock of aerpio pharmaceuticals incparties aerpio pharmaceuticals inc  aerpio pharmaceuticals inc law firm goodwin procter document date  governing lawunited states of america  receivables purchase agreementparties toyota auto finance receivables llc  toyota motor credit corporation document date  governing lawnew york  turner enters into acquisition agreement for operating bitumen tanker assetsparties turner valley oil gas inc  turner valley oil and gas inc  turner venture group inc document date   warrant to purchase stockparties yext inc  alpha creations corporation  silicon valley bank  svb financial group document date  governing lawcalifornia  warrant to purchase common stockparties okta inc  okta inc  silicon valley bank  svb financial group document date  governing lawcalifornia  form of warrant to purchase common stockparties gemphire therapeutics inc  gemphire therapeutics inc document date  governing lawnew york  warrant to purchase stockparties okta inc  okta inc  silicon valley bank  svb financial group law firm goodwin procter document date  governing lawcalifornia  warrant to purchase stockparties yext inc  alpha creations corporation  silicon valley bank  svb financial group  yext inc document date  governing lawcalifornia  sixth amended and restated right of first refusal and cosale agreementparties yext inc  g leonard baker jr and mary anne baker co  insight venture associates viii ltd  institutional venture management xi llc  institutional venture management xii llc  institutional venture partners xi gmbh co  leland stanford junior university  managing limited  marker ii gp ltd  michael l speiser and mary elizabeth speiser co  naar family trust  samuel j pullara iii and lucia choi pullara co  tench coxe and semone otus coxe co  tench coxe and simone otus coxe co  wells fargo bank na  wells fargo na  wgi group llc  white family trust  yext inc  yin family trust law firm cooley godwardlowenstein sandler document date  governing lawnew york  stock purchase agreementparties mmex resources corp  maple resources corporation  mmex resources corporation document date  governing lawtexas  purchase agreementparties pennymac mortgage investment trust  keefe bruyette woods inc  morgan stanley co llc  operating partnership  rbc capital markets llc law firm sidley austinvenablesullivan cromwell document date  governing lawnew york  warrant to purchase stockparties tocagen inc  oxford finance llc  silicon valley bank document date  governing lawcalifornia  tocagen inc warrant to purchase common stockparties tocagen inc document date  governing lawcalifornia  form of receivables purchase agreementparties toyota auto finance receivables llc  toyota motor credit corporation document date  governing lawnew york  warrant to purchase stockparties tocagen inc  oxford finance llc  silicon valley bank  svb financial group document date  governing lawcalifornia  forward purchase agreement parties olin corp  bank of america na  bank of oklahoma  bokf na  branch banking and trust company  gulf opportunity revenue bonds olin corporation  industrial development authority  northern trust company  pnc bank national association  pnc capital markets llc  recovery zone facility revenue bonds olin corporation  wells fargo bank na document date  governing lawnew york  first amendment to note purchase agreementparties aerie pharmaceuticals inc  aerie pharmaceuticals inc  deerfield private design fund iii lp deerfield international master fund lp deerfield partners lp  deerfield special situations fund lp  je flynn capital iii llc  je flynn capital llc document date  governing lawnew york  form of warrant to purchase stockparties tandem diabetes care inc  capital royalty partners  parallel fund b cayman lp  tandem diabetes care inc document date  governing lawcalifornia  modern media acquisition corp incorporated under the laws of the state of delaware units consisting of one share of common stock and onehalf of one warrant each whole warrant entitling the holder to purchase one share of common stockparties modern media acquisition corp  modern media acquisition corp document date  governing lawnew york  the number of shares of common stock issuable upon exercise of this warrant may be less than the amounts set forth on the face hereofparties fibrocell science inc  fibrocell science inc document date  governing lawnew york  purchase agreementparties molson coors brewing co  cbc holdco  llc  cbc holdco  inc  cbc holdco llc  citigroup global markets inc  high grade transaction management  jacob leinenkugel brewing co llc  mc holding company llc  merrill lynch pierce fenner smith incorporated  millercoors holdings llc  millercoors llc  molson coors brewing company  molson coors holdco inc  newco inc  ubs securities llc law firm davis polkperkins coiekirkland ellis document date  governing lawnew york  heat biologics announces agreement to acquire pelican therapeuticsparties heat biologics inc  heat biologics inc  pelican therapeutics inc document date   warrant agreement between kayne anderson acquisition corp and american stock transfer trust company llcparties kayne anderson acquisition corp  american stock transfer trust company llc  kayne anderson sponsor llc document date  governing lawnew york  warrant to purchase common sharesparties sanchez energy corp  gso st holdings associates llc  gso st holdings lp  intrepid private equity fund gp llc  intrepid private equity va llc  sanchez energy corporation  sn ef unsub gp llc  sn ef unsub holdings llc  sn ef unsub lp  sn ur holdings llc law firm baker bottskirkland ellis document date  governing lawdelaware browse by statego directly to a specific page of results